BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, Szer J, Lipton J, Schwendener A, Gratwohl M, Frauendorfer K, Niederwieser D, Horowitz M, Kodera Y; Worldwide Network of Blood and Marrow Transplantation. Hematopoietic stem cell transplantation: a global perspective. JAMA 2010;303:1617-24. [PMID: 20424252 DOI: 10.1001/jama.2010.491] [Cited by in Crossref: 446] [Cited by in F6Publishing: 377] [Article Influence: 37.2] [Reference Citation Analysis]
Number Citing Articles
1 Pilon S, Jedrysiak D, Sheppard D, Bredeson CN, Tay J, Allan DS. Current Trends in Clinical Studies of Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2015;21:364-70. [DOI: 10.1016/j.bbmt.2014.09.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
2 Singh J, Chen ELY, Xing Y, Stefanski HE, Blazar BR, Zúñiga-Pflücker JC. Generation and function of progenitor T cells from StemRegenin-1-expanded CD34+ human hematopoietic progenitor cells. Blood Adv 2019;3:2934-48. [PMID: 31648315 DOI: 10.1182/bloodadvances.2018026575] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
3 Eckrich M, Pasquini M. Hematopoietic cell transplantation in Latin America. Hematology 2012;17:s189-91. [DOI: 10.1179/102453312x13336169157059] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
4 Ariza-Heredia EJ, Chemaly RF, Shahani LR, Jang Y, Champlin RE, Mulanovich VE. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Transpl Int 2018;31:639-48. [PMID: 29464765 DOI: 10.1111/tri.13142] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
5 Salomao M, Dorritie K, Mapara MY, Sepulveda A. Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver:  An Update. Am J Clin Pathol 2016;145:591-603. [PMID: 27247365 DOI: 10.1093/ajcp/aqw050] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
6 Lown RN, Shaw BE. Beating the odds: factors implicated in the speed and availability of unrelated haematopoietic cell donor provision. Bone Marrow Transplant 2013;48:210-9. [DOI: 10.1038/bmt.2012.54] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
7 Magenau J, Braun T, Gatza E, Churay T, Mazzoli A, Chappell G, Brisson J, Runaas L, Anand S, Ghosh M, Riwes M, Pawarode A, Yanik G, Reddy P, Choi SW. Assessment of Individual versus Composite Endpoints of Acute Graft-versus-Host Disease in Determining Long-Term Survival after Allogeneic Transplantation. Biol Blood Marrow Transplant 2019;25:1682-8. [PMID: 30710686 DOI: 10.1016/j.bbmt.2019.01.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
8 Gratwohl A, Baldomero H, Gratwohl M, Aljurf M, Bouzas LF, Horowitz M, Kodera Y, Lipton J, Iida M, Pasquini MC, Passweg J, Szer J, Madrigal A, Frauendorfer K, Niederwieser D; Worldwide Network of Blood and Marrow Transplantation (WBMT). Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study. Haematologica 2013;98:1282-90. [PMID: 23508009 DOI: 10.3324/haematol.2012.076349] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
9 Singh J, Zúñiga-Pflücker JC. Producing proT cells to promote immunotherapies. Int Immunol 2018;30:541-50. [PMID: 30102361 DOI: 10.1093/intimm/dxy051] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Snowden JA, Saccardi R, Allez M, Ardizzone S, Arnold R, Cervera R, Denton C, Hawkey C, Labopin M, Mancardi G. Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012;47:770-790. [PMID: 22002489 DOI: 10.1038/bmt.2011.185] [Cited by in Crossref: 190] [Cited by in F6Publishing: 172] [Article Influence: 17.3] [Reference Citation Analysis]
11 Gratwohl A, Brand R, Niederwieser D, Baldomero H, Chabannon C, Cornelissen J, de Witte T, Ljungman P, McDonald F, McGrath E, Passweg J, Peters C, Rocha V, Slaper-Cortenbach I, Sureda A, Tichelli A, Apperley J. Introduction of a quality management system and outcome after hematopoietic stem-cell transplantation. J Clin Oncol 2011;29:1980-6. [PMID: 21483006 DOI: 10.1200/JCO.2010.30.4121] [Cited by in Crossref: 68] [Cited by in F6Publishing: 18] [Article Influence: 6.2] [Reference Citation Analysis]
12 Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A. Different doses of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2014:CD010984. [PMID: 25722652 DOI: 10.1002/14651858.CD010984] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 An K, Wang Y, Li B, Luo C, Wang J, Luo C, Chen J. Prognostic factors and outcome of patients undergoing hematopoietic stem cell transplantation who are admitted to pediatric intensive care unit. BMC Pediatr. 2016;16:138. [PMID: 27544347 DOI: 10.1186/s12887-016-0669-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
14 Jabbour J, Manana B, Zahreddine A, Saade C, Charafeddine M, Bazarbachi A, Blaise D, El-Cheikh J. Sarcopenic obesity derived from PET/CT predicts mortality in lymphoma patients undergoing hematopoietic stem cell transplantation. Curr Res Transl Med 2019;67:93-9. [PMID: 30583985 DOI: 10.1016/j.retram.2018.12.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
15 Savani BN. Transplantation in AML CR1. Blood 2010;116:1822-3. [DOI: 10.1182/blood-2010-06-291500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
16 Billen A, Madrigal JA, Shaw BE. A review of the haematopoietic stem cell donation experience: is there room for improvement? Bone Marrow Transplant 2014;49:729-36. [DOI: 10.1038/bmt.2013.227] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
17 Garbutcheon-Singh KB, Fernández-Peñas P. Phototherapy for the treatment of cutaneous graft versus host disease. Australas J Dermatol 2015;56:93-9. [PMID: 25302552 DOI: 10.1111/ajd.12191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
18 Khera N, Deeg HJ, Kodish E, Rondelli D, Majhail N. Allogeneic Hematopoietic Cell Transplantation and Other Expensive Cellular Therapies: A Miracle for the Few but Off Limits to Many? J Clin Oncol 2020;38:1268-72. [PMID: 31730388 DOI: 10.1200/JCO.19.02232] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Memoli MJ, Athota R, Reed S, Czajkowski L, Bristol T, Proudfoot K, Hagey R, Voell J, Fiorentino C, Ademposi A, Shoham S, Taubenberger JK. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts. Clin Infect Dis 2014;58:214-24. [PMID: 24186906 DOI: 10.1093/cid/cit725] [Cited by in Crossref: 135] [Cited by in F6Publishing: 115] [Article Influence: 15.0] [Reference Citation Analysis]
20 Caldera F, Mercer M, Samson SI, Pitt JM, Hayney MS. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity. Vaccine 2021;39 Suppl 1:A15-23. [PMID: 33422377 DOI: 10.1016/j.vaccine.2020.11.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
21 Savani BN, Griffith ML, Jagasia S, Lee SJ. How I treat late effects in adults after allogeneic stem cell transplantation. Blood 2011;117:3002-9. [PMID: 21193694 DOI: 10.1182/blood-2010-10-263095] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 6.9] [Reference Citation Analysis]
22 Weidner AS, Panarelli NC, Rennert H, Jessurun J, Yantiss RK. Immunohistochemistry Improves the Detection of Adenovirus in Gastrointestinal Biopsy Specimens From Hematopoietic Stem Cell Transplant Recipients. Am J Clin Pathol 2016;146:627-31. [PMID: 27744342 DOI: 10.1093/ajcp/aqw179] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
23 Ahmed O, Ward TJ, Lungren MP, Abdelrazek Mohammed MA, Hofmann LV, Sze DY, Kothary N. Assessing the Risk of Hemorrhagic Complication following Transjugular Liver Biopsy in Bone Marrow Transplantation Recipients. J Vasc Interv Radiol 2016;27:551-7. [PMID: 26948328 DOI: 10.1016/j.jvir.2016.01.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
24 Lin JN, Chen HJ, Yang CH, Lai CH, Lin HH, Chang CS, Liang JA. Risk of osteoporosis and pathologic fractures in cancer patients who underwent hematopoietic stem cell transplantation: a nationwide retrospective cohort study. Oncotarget 2017;8:34811-9. [PMID: 28422731 DOI: 10.18632/oncotarget.16746] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
25 Yadav H, Nolan ME, Bohman JK, Cartin-Ceba R, Peters SG, Hogan WJ, Gajic O, Kor DJ. Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation. Crit Care Med. 2016;44:1082-1090. [PMID: 26807683 DOI: 10.1097/ccm.0000000000001617] [Cited by in Crossref: 39] [Cited by in F6Publishing: 14] [Article Influence: 7.8] [Reference Citation Analysis]
26 Gholaminezhad S, Hadjibabaie M, Gholami K, Javadi MR, Radfar M, Karimzadeh I, Ghavamzadeh A. Pattern and associated factors of potential drug-drug interactions in both pre- and early post-hematopoietic stem cell transplantation stages at a referral center in the Middle East. Ann Hematol 2014;93:1913-22. [DOI: 10.1007/s00277-014-2122-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Muhsen IN, Aljurf M, Wingard JR, Poland GA, Komanduri KV, Whitaker JA, Hashmi SK. Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives. Vaccine 2018;36:6043-52. [PMID: 30195488 DOI: 10.1016/j.vaccine.2018.08.044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
28 Passweg JR, Baldomero H, Basak GW, Chabannon C, Corbacioglu S, Duarte R, Kuball J, Lankester A, Montoto S, de Latour RP, Snowden JA, Styczynski J, Yakoub-Agha I, Arat M, Mohty M, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies. Bone Marrow Transplant 2019;54:1575-85. [PMID: 30728439 DOI: 10.1038/s41409-019-0465-9] [Cited by in Crossref: 79] [Cited by in F6Publishing: 63] [Article Influence: 26.3] [Reference Citation Analysis]
29 Lim J, Cho B, Min C, Park G, Kim Y, Chung N, Jeong D, Min W. Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease. Immunological Investigations 2013;43:41-53. [DOI: 10.3109/08820139.2013.843191] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
30 Kuwatsuka Y. Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries. Int J Hematol 2016;103:20-4. [DOI: 10.1007/s12185-015-1896-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
31 Choi M, Kim MS, Park SY, Park GH, Jo SJ, Cho KH, Lee JW, Park KD, Shin HY, Kang HJ, Kwon O. Clinical characteristics of chemotherapy-induced alopecia in childhood. Journal of the American Academy of Dermatology 2014;70:499-505. [DOI: 10.1016/j.jaad.2013.10.034] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
32 Morello E, Malagola M, Bernardi S, Pristipino C, Russo D. The role of allogeneic hematopoietic stem cell transplantation in the four P medicine era. Blood Res 2018;53:3-6. [PMID: 29662853 DOI: 10.5045/br.2018.53.1.3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
33 Passweg JR, Baldomero H, Bregni M, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Kröger N, Farge-Bancel D, Gaspar HB, Marsh J, Mohty M, Peters C, Sureda A, Velardi A, Ruiz de Elvira C, Madrigal A; European Group for Blood and Marrow Transplantation. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013;48:1161-7. [PMID: 23584439 DOI: 10.1038/bmt.2013.51] [Cited by in Crossref: 84] [Cited by in F6Publishing: 80] [Article Influence: 9.3] [Reference Citation Analysis]
34 Hendijani F, Haghjooy Javanmard S, Sadeghi-aliabadi H. Human Wharton's jelly mesenchymal stem cell secretome display antiproliferative effect on leukemia cell line and produce additive cytotoxic effect in combination with doxorubicin. Tissue and Cell 2015;47:229-34. [DOI: 10.1016/j.tice.2015.01.005] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
35 Niederwieser C, Starke S, Fischer L, Krahl R, Beck J, Gruhn B, Ebell W, Körholz D, Wößmann W, Bader P, Lang P, Al-ali H, Cross M, Eisfeld A, Heyn S, Vucinic V, Franke G, Lange T, Pönisch W, Behre G, Christiansen H. Favorable outcome in children and adolescents with a high proportion of advanced phase disease using single/multiple autologous or matched/mismatched allogeneic stem cell transplantations. Ann Hematol 2016;95:473-81. [DOI: 10.1007/s00277-015-2569-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Antonic A, Sena ES, Lees JS, Wills TE, Skeers P, Batchelor PE, Macleod MR, Howells DW. Stem cell transplantation in traumatic spinal cord injury: a systematic review and meta-analysis of animal studies. PLoS Biol 2013;11:e1001738. [PMID: 24358022 DOI: 10.1371/journal.pbio.1001738] [Cited by in Crossref: 84] [Cited by in F6Publishing: 79] [Article Influence: 9.3] [Reference Citation Analysis]
37 van Walraven SM, Brand A, Bakker JN, Heemskerk MB, Nillesen S, Bierings MB, Bungener LB, Hepkema BG, Lankester A, van der Meer A, Sintnicolaas K, Somers JA, Spierings E, Tilanus MG, Voorter CE, Cornelissen JJ, Oudshoorn M. The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent. Haematologica 2017;102:176-83. [PMID: 27561721 DOI: 10.3324/haematol.2016.145730] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
38 Jaimovich G, Martinez Rolon J, Baldomero H, Rivas M, Hanesman I, Bouzas L, Bonfim C, Palma J, Kardus-urueta A, Ubidia D, Bujan-boza W, Gonzalez-ramella O, Ruiz-argüelles G, Gomez-almaguer D, Espino G, Fanilla E, Gonzalez D, Carrasco A, Galeano S, Borelli G, Hernandez-gimenez M, Pasquini M, Kodera Y, Gratwohl A, Gratwohl M, Nuñez J, Szer J, Gale RP, Niederwieser D, Seber A. Latin America: the next region for haematopoietic transplant progress. Bone Marrow Transplant 2017;52:671-7. [DOI: 10.1038/bmt.2016.361] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
39 Tiwari AK, Bhati-Kushwaha H, Kukreja P, Mishra VC, Tyagi N, Sharma A, Raina V. Probability of Finding Marrow Unrelated Donor (MUD) for an Indian patient in a Multi-national Human Leukocyte Antigen (HLA) Registry. Indian J Hematol Blood Transfus 2015;31:186-95. [PMID: 25825557 DOI: 10.1007/s12288-014-0416-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
40 Salas MQ, Chen S, Lam W, Pasic I, Gerbitz A, Michelis FV, Kim D(H, Al-shaibani Z, Lipton JH, Mattsson J, Kumar R, Viswabandya A, Law AD. Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia. Biology of Blood and Marrow Transplantation 2020;26:1511-9. [DOI: 10.1016/j.bbmt.2020.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 de Faveri GN, Schwabe R, Bart T. Swiss Blood Stem Cells: More than Just a Registry. Transfus Med Hemother 2011;38:300-7. [PMID: 22670119 DOI: 10.1159/000331493] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
42 Gratwohl A. Allogeneic Hematopoietic Stem-Cell Transplantation for Myeloma: It's Time for the Appropriate Studies. JCO 2011;29:e483-e483. [DOI: 10.1200/jco.2010.34.4481] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
43 Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale GA, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J. Worldwide Network for Blood and Marrow Transplantation Recommendations for Establishing a Hematopoietic Cell Transplantation Program, Part I: Minimum Requirements and Beyond. Biology of Blood and Marrow Transplantation 2019;25:2322-9. [DOI: 10.1016/j.bbmt.2019.05.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
44 Mathur P, Paydak H, Thanendrarajan S, van Rhee F. Atrial Fibrillation in Hematologic Malignancies, Especially After Autologous Hematopoietic Stem Cell Transplantation: Review of Risk Factors, Current Management, and Future Directions. Clinical Lymphoma Myeloma and Leukemia 2016;16:70-5. [DOI: 10.1016/j.clml.2015.10.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
45 Gratwohl A, Sureda A, Cornelissen J, Apperley J, Dreger P, Duarte R, Greinix HT, Mc Grath E, Kroeger N, Lanza F, Nagler A, Snowden JA, Niederwieser D, Brand R; for the European Society for Blood and Marrow Transplantation (EBMT). Alloreactivity: the Janus-face of hematopoietic stem cell transplantation. Leukemia 2017;31:1752-9. [DOI: 10.1038/leu.2017.79] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
46 Vande Vusse LK, Madtes DK. Early Onset Noninfectious Pulmonary Syndromes after Hematopoietic Cell Transplantation. Clin Chest Med 2017;38:233-48. [PMID: 28477636 DOI: 10.1016/j.ccm.2016.12.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 2.8] [Reference Citation Analysis]
47 Hussain F, Chaudhri N, Alfraih F, Aljurf M. Current concepts on hematopoietic stem cell transplantation outcome registries; Emphases on resource requirements for new registries. Hematol Oncol Stem Cell Ther 2017;10:203-10. [PMID: 28751034 DOI: 10.1016/j.hemonc.2017.05.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
48 Kamada M, Kumazaki T, Matsuo T, Mitsui Y, Takahashi T. Establishment of ultra long-lived cell lines by transfection of TERT into normal human fibroblast TIG-1 and their characterization. Cell Biol Int 2012;36:519-27. [PMID: 22273270 DOI: 10.1042/CBI20110460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
49 Posluszny, JA, Gamelli RL, Shankar R. Hematologic and hematopoietic response to burn injury. Total Burn Care. Elsevier; 2012. pp. 277-288.e8. [DOI: 10.1016/b978-1-4377-2786-9.00023-0] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
50 Worel N, Buser A, Greinix HT, Hägglund H, Navarro W, Pulsipher MA, Nicoloso de Faveri G, Bengtsson M, Billen A, Espino G, Fechter M, Giudice V, Hölig K, Kanamori H, Kodera Y, Leitner G, Netelenbos T, Niederwieser D, van Walraven SM, Rocha V, Torosian T, Vergueiro C, Weisdorf D, Yabe H, Halter JP. Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues. Biol Blood Marrow Transplant 2015;21:2052-60. [PMID: 26271194 DOI: 10.1016/j.bbmt.2015.08.009] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
51 Lemiale V, Pons S, Mirouse A, Tudesq JJ, Hourmant Y, Mokart D, Pène F, Kouatchet A, Mayaux J, Nyunga M, Bruneel F, Meert AP, Borcoman E, Bisbal M, Legrand M, Benoit D, Azoulay E, Darmon M, Zafrani L. Sepsis and Septic Shock in Patients With Malignancies: A Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study. Crit Care Med 2020;48:822-9. [PMID: 32317596 DOI: 10.1097/CCM.0000000000004322] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
52 de Souza AM, Hamerschlak N, Kutner JM. Young haploidentical donor versus fully matched elderly donor: An observational study on patients aged 50 years or older underwent hematopoietic progenitor cells transplantation. Transfus Apher Sci 2021;60:103032. [PMID: 33483283 DOI: 10.1016/j.transci.2020.103032] [Reference Citation Analysis]
53 Reddy N, Rezvani K, Barrett AJ, Savani BN. Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients. Biol Blood Marrow Transplant 2011;17:591-7. [PMID: 20732435 DOI: 10.1016/j.bbmt.2010.08.007] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 4.5] [Reference Citation Analysis]
54 Xu LP, Lu PH, Wu DP, Sun ZM, Liu QF, Han MZ, Zhang X, Song YP, Song XM, Hu JD, Huang H, Lai YR, Wan DM, Chen J, Li CF, Xia LH, Wang JB, Liu DH, Huang XJ; Chinese Blood and Marrow Transplantation Registry Group. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant 2021. [PMID: 34433917 DOI: 10.1038/s41409-021-01431-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Hung Y, Bauer J, Horsley P, Waterhouse M, Bashford J, Isenring E. Changes in nutritional status, body composition, quality of life, and physical activity levels of cancer patients undergoing autologous peripheral blood stem cell transplantation. Support Care Cancer 2013;21:1579-86. [DOI: 10.1007/s00520-012-1698-y] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
56 Nakane T, Nakamae M, Koh H, Nishimoto M, Nakashima Y, Hirose A, Hino M, Nakamae H. Autonomic Nervous System Pretransplant Malfunction Is a Powerful Predictor of Survival After Allogeneic Hematopoietic Cell Transplantation. Transplantation 2017;101:2801-9. [PMID: 28505024 DOI: 10.1097/TP.0000000000001813] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
57 Benakli M, Ahmed Nacer R, Mehdid F, Belhadj R, Talbi A, Rahmoune N, Niederwieser C, Baazizi M, Akhrouf S, Ait Ouali D, Bouarab H, Zerkout S, Abderahim I, Harieche F, Hamladji R. Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria. Ann Hematol 2020;99:619-25. [DOI: 10.1007/s00277-020-03914-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Snowden JA, Pearce RM, Lee J, Kirkland K, Gilleece M, Veys P, Clark RE, Kazmi M, Abinun M, Jackson GH, Mackinnon S, Russell NH, Cook G; on behalf of the BSBMT Clinical Trials Committee. Haematopoietic stem cell transplantation (HSCT) in severe autoimmune diseases: analysis of UK outcomes from the British Society of Blood and Marrow Transplantation (BSBMT) data registry 1997-2009. Br J Haematol 2012;157:742-6. [DOI: 10.1111/j.1365-2141.2012.09122.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
59 Kim DH, Ha EJ, Park SJ, Koh KN, Kim H, Im HJ, Jhang WK. Prognostic factors of pediatric hematopoietic stem cell transplantation recipients admitted to the pediatric intensive care unit. Acute Crit Care 2021. [PMID: 34736299 DOI: 10.4266/acc.2020.01193] [Reference Citation Analysis]
60 Valenta S, De Geest S, Fierz K, Beckmann S, Halter J, Schanz U, Nair G, Kirsch M. Perception of late effects among long-term survivors after haematopoietic stem cell transplantation: Descriptive analysis and validation of the Brief Illness Perception Questionnaire. A sub-study of the PROVIVO study. Eur J Oncol Nurs 2017;27:17-27. [PMID: 28279392 DOI: 10.1016/j.ejon.2017.01.003] [Reference Citation Analysis]
61 Preussler JM, Denzen EM, Majhail NS. Costs and cost-effectiveness of hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012;18:1620-8. [PMID: 22484549 DOI: 10.1016/j.bbmt.2012.04.001] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 5.1] [Reference Citation Analysis]
62 von Bonin M, Bornhäuser M. Concise Review: The Bone Marrow Niche as a Target of Graft Versus Host Disease: Bone marrow GvHD. Stem Cells 2014;32:1420-8. [DOI: 10.1002/stem.1691] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
63 Chan WK, Suwannasaen D, Throm RE, Li Y, Eldridge PW, Houston J, Gray JT, Pui CH, Leung W. Chimeric antigen receptor-redirected CD45RA-negative T cells have potent antileukemia and pathogen memory response without graft-versus-host activity. Leukemia 2015;29:387-95. [PMID: 24888271 DOI: 10.1038/leu.2014.174] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
64 Chen W, Li M, Li Z, Yan Z, Cheng H, Pan B, Cao J, Chen C, Zeng L, Xu K. CXCR4-transduced mesenchymal stem cells protect mice against graft-versus-host disease. Immunology Letters 2012;143:161-9. [DOI: 10.1016/j.imlet.2012.01.015] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
65 Frascino AV, Fava M, Collassanti MDS, Odone-Filho V. Impact of Pediatric Hematopoietic Stem-Cell Transplantation on Craniofacial Growth. Clinics (Sao Paulo) 2020;75:e1901. [PMID: 33146356 DOI: 10.6061/clinics/2020/e1901] [Reference Citation Analysis]
66 Tiewsiri K, Manipalviratn S, Sutheesophon W, Vanichsetakul P, Thaijaroen P, Ketcharoon P, Bradley CK, McArthur SJ, Krutsawad W, Marshall JTA, Papadopoulos KI. The First Asian, Single-Center Experience of Blastocyst Preimplantation Genetic Diagnosis with HLA Matching in Thailand for the Prevention of Thalassemia and Subsequent Curative Hematopoietic Stem Cell Transplantation of Twelve Affected Siblings. Biomed Res Int 2020;2020:5292090. [PMID: 32685500 DOI: 10.1155/2020/5292090] [Reference Citation Analysis]
67 Hunt CJ. Cryopreservation of Human Stem Cells for Clinical Application: A Review. Transfus Med Hemother. 2011;38:107-123. [PMID: 21566712 DOI: 10.1159/000326623] [Cited by in Crossref: 197] [Cited by in F6Publishing: 169] [Article Influence: 17.9] [Reference Citation Analysis]
68 Gratwohl A, Sureda A, Baldomero H, Gratwohl M, Dreger P, Kröger N, Ljungman P, McGrath E, Mohty M, Nagler A, Rambaldi A, de Elvira CR, Snowden JA, Passweg J, Apperley J, Niederwieser D, Stijnen T, Brand R; Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy (ISCT) and the European Society for Blood and Marrow Transplantation (EBMT) and the European Leukemia Net (ELN). Economics and Outcome After Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study. EBioMedicine 2015;2:2101-9. [PMID: 26844291 DOI: 10.1016/j.ebiom.2015.11.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
69 Estcourt LJ, Crighton GL, Wood EM, Stanworth S, Trivella M, Doree C, Tinmouth A, Murphy MF. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2014:CD010981. [PMID: 25722649 DOI: 10.1002/14651858.CD010981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
70 Passweg JR, Baldomero H, Peters C, Gaspar HB, Cesaro S, Dreger P, Duarte RF, Falkenburg JH, Farge-Bancel D, Gennery A, Halter J, Kröger N, Lanza F, Marsh J, Mohty M, Sureda A, Velardi A, Madrigal A; European Society for Blood and Marrow Transplantation EBMT. Hematopoietic SCT in Europe: data and trends in 2012 with special consideration of pediatric transplantation. Bone Marrow Transplant 2014;49:744-50. [PMID: 24637898 DOI: 10.1038/bmt.2014.55] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 13.8] [Reference Citation Analysis]
71 Brügger U, Ruckstuhl A, Horisberger B, Gratwohl A. DEVELOPMENT OF COVERAGE WITH EVIDENCE DEVELOPMENT FOR MEDICAL TECHNOLOGIES IN SWITZERLAND FROM 1996 TO 2012. Int J Technol Assess Health Care 2014;30:253-9. [DOI: 10.1017/s0266462314000233] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
72 Bräuninger S, Thorausch K, Luxembourg B, Schulz M, Chow KU, Seifried E, Bonig H. Deferrals of volunteer stem cell donors referred for evaluation for matched-unrelated stem cell donation. Bone Marrow Transplant 2014;49:1419-25. [DOI: 10.1038/bmt.2014.171] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
73 Hemminki O, Dos Santos JM, Hemminki A. Oncolytic viruses for cancer immunotherapy. J Hematol Oncol 2020;13:84. [PMID: 32600470 DOI: 10.1186/s13045-020-00922-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 11.5] [Reference Citation Analysis]
74 Hashmi S, Carpenter P, Khera N, Tichelli A, Savani BN. Lost in Transition: The Essential Need for Long-Term Follow-Up Clinic for Blood and Marrow Transplantation Survivors. Biology of Blood and Marrow Transplantation 2015;21:225-32. [DOI: 10.1016/j.bbmt.2014.06.035] [Cited by in Crossref: 64] [Cited by in F6Publishing: 46] [Article Influence: 9.1] [Reference Citation Analysis]
75 Giebel S, Labopin M, Ibatici A, Browne P, Czerw T, Socie G, Unal A, Kyrcz-Krzemien S, Bacigalupo A, Goker H, Potter M, Furness CL, McQuaker G, Beelen D, Milpied N, Campos A, Craddock C, Nagler A, Mohty M. Association of Macroeconomic Factors With Nonrelapse Mortality After Allogeneic Hematopoietic Cell Transplantation for Adults With Acute Lymphoblastic Leukemia: An Analysis From the Acute Leukemia Working Party of the EBMT. Oncologist 2016;21:377-83. [PMID: 26869584 DOI: 10.1634/theoncologist.2015-0314] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
76 Radich J. Stem cell transplant for chronic myeloid leukemia in the imatinib era. Semin Hematol 2010;47:354-61. [PMID: 20875552 DOI: 10.1053/j.seminhematol.2010.06.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
77 Riddell J, Gazit R, Garrison BS, Guo G, Saadatpour A, Mandal PK, Ebina W, Volchkov P, Yuan GC, Orkin SH, Rossi DJ. Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell 2014;157:549-64. [PMID: 24766805 DOI: 10.1016/j.cell.2014.04.006] [Cited by in Crossref: 228] [Cited by in F6Publishing: 210] [Article Influence: 28.5] [Reference Citation Analysis]
78 Mtenga J, Orf K, Zheng J, Chamba C, Chuwa H, Luoga F, Malangahe SW, Iversen PO, Makani J. Haematopoietic stem cell transplantation in Tanzania. Br J Haematol 2021;192:17-21. [PMID: 32976624 DOI: 10.1111/bjh.17106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Laaksonen M, Ramseier A, Rovó A, Jensen S, Raber-durlacher J, Zitzmann N, Waltimo T. Longitudinal Assessment of Hematopoietic Stem Cell Transplantation and Hyposalivation. J Dent Res 2011;90:1177-82. [DOI: 10.1177/0022034511414156] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
80 Alsalamah S, Alramyan R, Alakel R, Altheyeb F, Alrashed R, Masuadi E, Alyousif G, Bin Sunaid FF, Alsultan A, Essa MF. The outcome and complications of total parenteral nutrition in pediatric hematopoietic stem cell transplantation. Pediatr Transplant 2021;:e14198. [PMID: 34811859 DOI: 10.1111/petr.14198] [Reference Citation Analysis]
81 Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kröger N, Kuball J, Lanza F, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2017;52:811-7. [PMID: 28287639 DOI: 10.1038/bmt.2017.34] [Cited by in Crossref: 210] [Cited by in F6Publishing: 195] [Article Influence: 42.0] [Reference Citation Analysis]
82 Innocentini LMAR, Silva AA, Carvalho MA, Coletta RD, Corrêa MEP, Bingle L, Bingle CD, Vargas PA, Lopes MA. Salivary BPIFA proteins are altered in patients undergoing hematopoietic cell transplantation. Oral Dis 2021. [PMID: 33682222 DOI: 10.1111/odi.13832] [Reference Citation Analysis]
83 El-Jawahri A, Fishman SR, Vanderklish J, Dizon DS, Pensak N, Traeger L, Greer JA, Park ER, Markovitz N, Waldman L, Hunnewell C, Saylor M, Driscoll J, Li Z, Spitzer TR, McAfee S, Chen YB, Temel JS. Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation. Cancer 2018;124:2438-46. [PMID: 29537491 DOI: 10.1002/cncr.31333] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
84 Golay H, Jurkovic Mlakar S, Mlakar V, Nava T, Ansari M. The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review. Int J Mol Sci 2019;20:E3889. [PMID: 31404983 DOI: 10.3390/ijms20163889] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
85 Jo T, Arai Y, Kondo T, Kitano T, Hishizawa M, Yamashita K, Takaori-Kondo A. Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute. Biol Blood Marrow Transplant 2017;23:2159-65. [PMID: 28822830 DOI: 10.1016/j.bbmt.2017.08.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
86 Rebulla P, Lecchi L. Towards responsible cord blood banking models. Cell Prolif 2011;44 Suppl 1:30-4. [PMID: 21481040 DOI: 10.1111/j.1365-2184.2010.00720.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
87 Salas MQ, Prem S, Atenafu EG, Datt Law A, Lam W, Al-shaibani Z, Loach D, Kim D(H, Michelis FV, Lipton JH, Kumar R, Mattsson J, Viswabandya A. Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD. Bone Marrow Transplant 2020;55:1773-83. [DOI: 10.1038/s41409-020-0813-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
88 Braamse AM, Gerrits MM, van Meijel B, Visser O, van Oppen P, Boenink AD, Cuijpers P, Huijgens PC, Beekman AT, Dekker J. Predictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies. Bone Marrow Transplant. 2012;47:757-769. [PMID: 21725373 DOI: 10.1038/bmt.2011.130] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
89 Klitz W, Hedrick P, Louis EJ. New reservoirs of HLA alleles: pools of rare variants enhance immune defense. Trends Genet 2012;28:480-6. [PMID: 22867968 DOI: 10.1016/j.tig.2012.06.007] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
90 Garcia JM, Mendonça L, Brant R, Abud M, Regatieri C, Diniz B. Stem cell therapy for retinal diseases. World J Stem Cells 2015; 7(1): 160-164 [PMID: 25621115 DOI: 10.4252/wjsc.v7.i1.160] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
91 Passweg JR, Baldomero H, Chabannon C, Basak GW, Corbacioglu S, Duarte R, Dolstra H, Lankester AC, Mohty M, Montoto S, Peffault de Latour R, Snowden JA, Styczynski J, Yakoub-Agha I, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T's come into focus. Bone Marrow Transplant 2020;55:1604-13. [PMID: 32066864 DOI: 10.1038/s41409-020-0826-4] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 27.5] [Reference Citation Analysis]
92 Jafari H, Jannati Y, Nesheli HM, Hassanpour S. Effects of nonpharmacological interventions on reducing fatigue after hematopoietic stem cell transplantation. J Res Med Sci 2017;22:13. [PMID: 28458705 DOI: 10.4103/1735-1995.199094] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
93 Sahoo F, Hill JA, Xie H, Leisenring W, Yi J, Goyal S, Kimball LE, Lee I, Seo S, Davis C, Pergam SA, Flowers ME, Liaw KL, Holmberg L, Boeckh M. Herpes Zoster in Autologous Hematopoietic Cell Transplant Recipients in the Era of Acyclovir or Valacyclovir Prophylaxis and Novel Treatment and Maintenance Therapies. Biol Blood Marrow Transplant 2017;23:505-11. [PMID: 28039754 DOI: 10.1016/j.bbmt.2016.12.620] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
94 Yu M, Wang J, Fang Q, Liu P, Chen S, Zhe N, Lin X, Zhang Y, Zhao J, Zhou Z. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg. Transpl Immunol 2016;37:10-7. [PMID: 27168057 DOI: 10.1016/j.trim.2016.05.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
95 Gonella S, Berchialla P, Bruno B, Di Giulio P. Are orange lollies effective in preventing nausea and vomiting related to dimethyl sulfoxide? A multicenter randomized trial. Support Care Cancer 2014;22:2417-24. [PMID: 24700260 DOI: 10.1007/s00520-014-2227-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
96 Gębura K, Butrym A, Chaszczewska-markowska M, Wróbel T, Kuliczkowski K, Bogunia-kubik K. G-CSF administration favours SDF-1 release and activation of neutrophils and monocytes in recipients of autologous peripheral blood progenitor cells. Cytokine 2019;116:38-47. [DOI: 10.1016/j.cyto.2018.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
97 Ebina W, Rossi DJ. Transcription factor-mediated reprogramming toward hematopoietic stem cells. EMBO J 2015;34:694-709. [PMID: 25712209 DOI: 10.15252/embj.201490804] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
98 Smagur A, Mitrus I, Ciomber A, Panczyniak K, Fidyk W, Sadus-wojciechowska M, Holowiecki J, Giebel S. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation. Vox Sang 2015;108:417-24. [DOI: 10.1111/vox.12238] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
99 Cruciani S, Santaniello S, Montella A, Ventura C, Maioli M. Orchestrating stem cell fate: Novel tools for regenerative medicine. World J Stem Cells 2019; 11(8): 464-475 [PMID: 31523367 DOI: 10.4252/wjsc.v11.i8.464] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
100 Saboo US, Amparo F, Shikari H, Dana R. Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease. Graefes Arch Clin Exp Ophthalmol 2016;254:923-8. [PMID: 26968719 DOI: 10.1007/s00417-016-3312-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
101 Fiuza-Luces C, González-Murillo A, Soares-Miranda L, Martínez Palacio J, Colmenero I, Casco F, Melén G, Morán M, Lucia A, Ramírez M. Effects of exercise interventions in graft-versus-host disease models. Cell Transplant 2013;22:2409-20. [PMID: 23127525 DOI: 10.3727/096368912X658746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
102 Harif M, Weisdorf D, Novitzky N, Szer J, Mahmal L, Benakli M, Ben Othman T, Bazuaye N, McGrath E, Eldridge PW, Torjemane L, Madani A, Ahmed Nacer R, Belkhedim R, Rasheed W, Ahmed SO, Kodera Y, Aljurf M, Niederwieser DW, Quessar A. Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19-21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT). Hematol Oncol Stem Cell Ther 2020;13:202-7. [PMID: 31181176 DOI: 10.1016/j.hemonc.2019.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
103 Nakasone H, Sahaf B, Miklos DB. Therapeutic benefits targeting B-cells in chronic graft-versus-host disease. Int J Hematol 2015;101:438-51. [PMID: 25812839 DOI: 10.1007/s12185-015-1782-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
104 Gratwohl A, Passweg J, Baldomero H, Orchard K, Kröger N, Snowden JA; Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy Europe (ISCT), the European Society for Blood, Marrow Transplantation (EBMT). Conditioning intensity before allogeneic haematopoietic stem cell transplantation: a quality control audit. Br J Haematol 2021;192:e151-4. [PMID: 33618431 DOI: 10.1111/bjh.17369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
105 Gorin NC, Giebel S, Labopin M, Savani BN, Mohty M, Nagler A. Autologous stem cell transplantation for adult acute leukemia in 2015: time to rethink? Present status and future prospects. Bone Marrow Transplant 2015;50:1495-502. [PMID: 26281031 DOI: 10.1038/bmt.2015.179] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
106 Kitchen SG, Zack JA. Stem cell-based approaches to treating HIV infection. Curr Opin HIV AIDS 2011;6:68-73. [PMID: 21242896 DOI: 10.1097/COH.0b013e3283412370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
107 Hansen HJ, Estilo C, Owosho A, Solano AK, Randazzo J, Huryn J, Yom SK. Dental status and risk of odontogenic complication in patients undergoing hematopoietic stem cell transplant. Support Care Cancer 2021;29:2231-8. [PMID: 32901321 DOI: 10.1007/s00520-020-05733-1] [Reference Citation Analysis]
108 Ghazi S, Alaskar A, Alzahrani M, Damlaj M, Abuelgasim KA, Gmati G, Alshami M, Alshammary S, Al-Surimi K, Salama H, Alhejazi A, Jazieh AR. Reducing Central Venous Catheter Use in Peripheral Blood Stem Cell Donation: Quality Improvement Report. BMJ Qual Improv Rep 2017;6:u211975. [PMID: 28469899 DOI: 10.1136/bmjquality.u211975.w4817] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
109 Moses SE, Lim Z, Zuckerman MA. Hepatitis B virus infection: pathogenesis, reactivation and management in hematopoietic stem cell transplant recipients. Expert Rev Anti Infect Ther. 2011;9:891-899. [PMID: 21973301 DOI: 10.1586/eri.11.105] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
110 Yildiz Kabak V, Duger T, Uckan Cetinkaya D. Investigation of the Effects of an Exercise Program on Physical Functions and Activities of Daily Life in Pediatric Hematopoietic Stem Cell Transplantation: Exercise in Pediatric Hematopoietic Stem Cell Transplantation. Pediatr Blood Cancer 2016;63:1643-8. [DOI: 10.1002/pbc.26038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
111 El-Jawahri A, Nelson AM, Gray TF, Lee SJ, LeBlanc TW. Palliative and End-of-Life Care for Patients With Hematologic Malignancies. J Clin Oncol 2020;38:944-53. [PMID: 32023164 DOI: 10.1200/JCO.18.02386] [Cited by in Crossref: 24] [Cited by in F6Publishing: 4] [Article Influence: 12.0] [Reference Citation Analysis]
112 Pingel J, Solloch UV, Hofmann JA, Lange V, Ehninger G, Schmidt AH. High-resolution HLA haplotype frequencies of stem cell donors in Germany with foreign parentage: How can they be used to improve unrelated donor searches? Human Immunology 2013;74:330-40. [DOI: 10.1016/j.humimm.2012.10.029] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 5.4] [Reference Citation Analysis]
113 Ganuza M, McKinney-Freeman S. Hematopoietic stem cells under pressure. Curr Opin Hematol 2017;24:314-21. [PMID: 28375987 DOI: 10.1097/MOH.0000000000000347] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
114 Dey BR, Yeh AC, Spitzer TR. Establishing the First Hematopoietic Stem Cell Transplant Unit in Nepal. Transplant Cell Ther 2022;28:223-4. [PMID: 35523473 DOI: 10.1016/j.jtct.2022.04.006] [Reference Citation Analysis]
115 Pirotte M, Forte F, Lutteri L, Willems E, Duran U, Belle L, Baron F, Beguin Y, Maquet P, Bodart O, Servais S. Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. J Neuroimmunol. 2018;323:115-118. [PMID: 30189384 DOI: 10.1016/j.jneuroim.2018.08.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
116 Martino M, Lanza F, Demirer T, Moscato T, Secondino S, Pedrazzoli P; European Society for Blood and Marrow Transplantation, Solid Tumors Working Party (EBMT-STWP). Erythropoiesis-stimulating agents in allogeneic and autologous hematopoietic stem cell transplantation. Expert Opin Biol Ther 2015;15:195-211. [PMID: 25315815 DOI: 10.1517/14712598.2015.971749] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
117 Wun CM, Piao Z, Hong KT, Choi JY, Hong CR, Park JD, Park KD, Shin HY, Kang HJ. Effect of donor STAT4 polymorphism rs7574865 on clinical outcomes of pediatric acute leukemia patients after hematopoietic stem cell transplant. Int Immunopharmacol 2017;43:62-9. [PMID: 27960128 DOI: 10.1016/j.intimp.2016.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
118 Rödling L, Volz EM, Raic A, Brändle K, Franzreb M, Lee-Thedieck C. Magnetic Macroporous Hydrogels as a Novel Approach for Perfused Stem Cell Culture in 3D Scaffolds via Contactless Motion Control. Adv Healthc Mater 2018;7:e1701403. [PMID: 29349923 DOI: 10.1002/adhm.201701403] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
119 Das K, Khanna T, Agrawal N. Establishing Hematopoietic Stem Cell Transplant Unit in Resource Limited Setting: A Critical Analysis of Indian Council of Medical Research 2017 Guidelines. J Transplant 2018;2018:1292307. [PMID: 30174945 DOI: 10.1155/2018/1292307] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
120 Sauter AW, Schmidt H, Mantlik F, Kolb A, Federmann B, Pfannenberg C, Reimold M, Pichler BJ, Bethge W, Horger MS. Imaging Findings and Therapy Response Monitoring in Chronic Sclerodermatous Graft-Versus-Host Disease: Preliminary Data of a Simultaneous PET/MRI Approach. Clinical Nuclear Medicine 2013;38:e309-17. [DOI: 10.1097/rlu.0b013e3182816559] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
121 Saillard C, Blaise D, Mokart D. Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis. Bone Marrow Transplant 2016;51:1050-61. [PMID: 27042832 DOI: 10.1038/bmt.2016.72] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
122 Özen M, Üstün C, Öztürk B, Topçuoğlu P, Arat M, Gündüz M, Atilla E, Bolat G, Arslan Ö, Demirer T, Akan H, İlhan O, Beksaç M, Gürman G, Özcan M. Allogeneic Transplantation in Chronic Myeloid Leukemia and the Effect of Tyrosine Kinase Inhibitors on Survival: A Quasi-Experimental Study. Turk J Haematol 2017;34:16-26. [PMID: 27094579 DOI: 10.4274/tjh.2015.0346] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
123 van Haren IEPM, Staal JB, Potting CM, Atsma F, Hoogeboom TJ, Blijlevens NMA, Nijhuis-van der Sanden MWG. Physical exercise prior to hematopoietic stem cell transplantation: A feasibility study. Physiotherapy Theory and Practice 2018;34:747-56. [DOI: 10.1080/09593985.2018.1423655] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
124 Rinaldi I, Louisa M, Wiguna FI, Budiani E, Mahardhika JC, Hukmi K. Prognostic Significance of Fms-Like Tyrosine Kinase 3 Internal Tandem Duplication Mutation in Non-Transplant Adult Patients with Acute Myeloblastic Leukemia: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 2020;21:2827-36. [PMID: 33112537 DOI: 10.31557/APJCP.2020.21.10.2827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
125 Papewalis C, Topolar D, Götz B, Schönberger S, Dilloo D. Mesenchymal stem cells as cellular immunotherapeutics in allogeneic hematopoietic stem cell transplantation. Adv Biochem Eng Biotechnol 2013;130:131-62. [PMID: 23455489 DOI: 10.1007/10_2012_158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
126 Martínez-Colón GJ, Taylor QM, Wilke CA, Podsiad AB, Moore BB. Elevated prostaglandin E2 post-bone marrow transplant mediates interleukin-1β-related lung injury. Mucosal Immunol 2018;11:319-32. [PMID: 28589946 DOI: 10.1038/mi.2017.51] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
127 Wulff-burchfield EM, Savani BN. Building a Transplantation Physician Workforce for Growing Need: Recruitment Starts during Residency. Biology of Blood and Marrow Transplantation 2013;19:1142-3. [DOI: 10.1016/j.bbmt.2013.05.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
128 Leung W, Campana D, Yang J, Pei D, Coustan-Smith E, Gan K, Rubnitz JE, Sandlund JT, Ribeiro RC, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Handgretinger R, Laver JH, Pui CH. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 2011;118:223-30. [PMID: 21613256 DOI: 10.1182/blood-2011-01-333070] [Cited by in Crossref: 124] [Cited by in F6Publishing: 104] [Article Influence: 11.3] [Reference Citation Analysis]
129 Ferreira MSV, Mousavi SH. Nanofiber technology in the ex vivo expansion of cord blood-derived hematopoietic stem cells. Nanomedicine 2018;14:1707-18. [PMID: 29753127 DOI: 10.1016/j.nano.2018.04.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
130 Sauvageau G, Humphries RK. Medicine. The blood stem cell Holy Grail? Science 2010;329:1291-2. [PMID: 20829472 DOI: 10.1126/science.1195173] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
131 Gowdy KM, Martinu T, Nugent JL, Manzo ND, Zhang HL, Kelly FL, Holtzman MJ, Palmer SM. Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infection. Transpl Immunol 2015;32:51-60. [PMID: 25446809 DOI: 10.1016/j.trim.2014.10.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
132 Caunday O, Agulles O, McGrath E, Empereur F, Stoltz JF, Chabannon C. Implementation of JACIE accreditation results in the establishment of new indicators that unevenly monitor processes contributing to the delivery of hematopoietic SCT. Bone Marrow Transplant 2013;48:604-9. [PMID: 23528642 DOI: 10.1038/bmt.2012.181] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
133 Bhatt NS, Brazauskas R, Salit RB, Syrjala K, Bo-Subait S, Tecca H, Badawy SM, Baker KS, Beitinjaneh A, Bejanyan N, Byrne M, Dias A, Farhadfar N, Freytes CO, Ganguly S, Hashmi S, Hayashi RJ, Hong S, Inamoto Y, Jamani K, Kasow KA, Khera N, Krem MM, Lazarus HM, Lee CJ, Lee S, Majhail NS, Malone AK, Marks DI, Mau LW, Mayo SJ, Muffly LS, Nathan S, Nishihori T, Page KM, Preussler J, Rangarajan HG, Rotz SJ, Salooja N, Savani BN, Schears R, Schechter-Finkelstein T, Schiller G, Shah AJ, Sharma A, Wang T, Wirk B, Battiwalla M, Schoemans H, Hamilton B, Buchbinder D, Phelan R, Shaw B. Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States. Transplant Cell Ther 2021;27:679.e1-8. [PMID: 33895402 DOI: 10.1016/j.jtct.2021.04.013] [Reference Citation Analysis]
134 Hakim A, Cooke KR, Pavletic SZ, Khalid M, Williams KM, Hashmi SK. Diagnosis and treatment of bronchiolitis obliterans syndrome accessible universally. Bone Marrow Transplant 2019;54:383-92. [PMID: 30038355 DOI: 10.1038/s41409-018-0266-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
135 Krohn-Grimberghe M, Mitchell MJ, Schloss MJ, Khan OF, Courties G, Guimaraes PPG, Rohde D, Cremer S, Kowalski PS, Sun Y, Tan M, Webster J, Wang K, Iwamoto Y, Schmidt SP, Wojtkiewicz GR, Nayar R, Frodermann V, Hulsmans M, Chung A, Hoyer FF, Swirski FK, Langer R, Anderson DG, Nahrendorf M. Nanoparticle-encapsulated siRNAs for gene silencing in the haematopoietic stem-cell niche. Nat Biomed Eng 2020;4:1076-89. [PMID: 33020600 DOI: 10.1038/s41551-020-00623-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
136 Bilmon IA, Ashton LJ, Le Marsney RE, Dodds AJ, O'Brien TA, Wilcox L, Nivison-Smith I, Daniels B, Vajdic CM; CAST study group. Second cancer risk in adults receiving autologous haematopoietic SCT for cancer: a population-based cohort study. Bone Marrow Transplant 2014;49:691-8. [PMID: 24535126 DOI: 10.1038/bmt.2014.13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
137 Khurana S, Melacarne A, Yadak R, Schouteden S, Notelaers T, Pistoni M, Maes C, Verfaillie CM. SMAD signaling regulates CXCL12 expression in the bone marrow niche, affecting homing and mobilization of hematopoietic progenitors. Stem Cells 2014;32:3012-22. [PMID: 25069965 DOI: 10.1002/stem.1794] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
138 Kingsley SM, Bhat BV. Could stem cells be the future therapy for sepsis? Blood Rev 2016;30:439-52. [PMID: 27297212 DOI: 10.1016/j.blre.2016.05.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
139 Debals-Gonthier M, Siani C, Faucher C, Touzani R, Lemarié-Basset C, Chabannon C, Furst S, Devillier R, Harbi S, Castagna L, Caymaris L, Blaise D, Le Corroller Soriano AG. Cost-effectiveness analysis of haploidentical vs matched unrelated allogeneic hematopoietic stem cells transplantation in patients older than 55 years. Bone Marrow Transplant 2018;53:1096-104. [PMID: 29523885 DOI: 10.1038/s41409-018-0133-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
140 Tessier SN, Weng L, Moyo WD, Au SH, Wong KHK, Angpraseuth C, Stoddard AE, Lu C, Nieman LT, Sandlin RD, Uygun K, Stott SL, Toner M. Effect of Ice Nucleation and Cryoprotectants during High Subzero-Preservation in Endothelialized Microchannels. ACS Biomater Sci Eng 2018;4:3006-15. [PMID: 31544149 DOI: 10.1021/acsbiomaterials.8b00648] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
141 Ehrhardt MJ, Brazauskas R, He W, Rizzo JD, Shaw BE. Survival of patients who develop solid tumors following hematopoietic stem cell transplantation. Bone Marrow Transplant 2016;51:83-8. [PMID: 26367222 DOI: 10.1038/bmt.2015.203] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
142 Juliusson G, Karlsson K, Lazarevic VL, Wahlin A, Brune M, Antunovic P, Derolf Å, Hägglund H, Karbach H, Lehmann S, Möllgård L, Stockelberg D, Hallböök H, Höglund M; for the Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leukemia Group. Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006. Cancer 2011;117:4238-46. [DOI: 10.1002/cncr.26033] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
143 Presland RB. Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications. Expert Review of Proteomics 2017;14:997-1006. [DOI: 10.1080/14789450.2017.1388166] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
144 Wulff-Burchfield EM, Jagasia M, Savani BN. Long-term follow-up of informal caregivers after allo-SCT: a systematic review. Bone Marrow Transplant 2013;48:469-73. [PMID: 22732697 DOI: 10.1038/bmt.2012.123] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
145 Tichelli A, Labopin M, Rovó A, Badoglio M, Arat M, van Lint MT, Lawitschka A, Schwarze CP, Passweg J, Socié G. Increase of suicide and accidental death after hematopoietic stem cell transplantation: a cohort study on behalf of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Cancer 2013;119:2012-21. [PMID: 23512286 DOI: 10.1002/cncr.27987] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
146 He J, Ogawa Y, Mukai S, Saijo-Ban Y, Kamoi M, Uchino M, Yamane M, Ozawa N, Fukui M, Mori T, Okamoto S, Tsubota K. In Vivo Confocal Microscopy Evaluation of Ocular Surface with Graft-Versus-Host Disease-Related Dry Eye Disease. Sci Rep 2017;7:10720. [PMID: 28878217 DOI: 10.1038/s41598-017-10237-w] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
147 Kanda J, Chiou LW, Szabolcs P, Sempowski GD, Rizzieri DA, Long GD, Sullivan KM, Gasparetto C, Chute JP, Morris A, McPherson J, Hale J, Livingston JA, Broadwater G, Niedzwiecki D, Chao NJ, Horwitz ME. Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant 2012;18:1664-1676.e1. [PMID: 22698485 DOI: 10.1016/j.bbmt.2012.06.005] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 6.6] [Reference Citation Analysis]
148 Bos-den Braber J, Potting CMJ, Bronkhorst EM, Huysmans MDNJM, Blijlevens NMA. Oral complaints and dental care of haematopoietic stem cell transplant patients: a qualitative survey of patients and their dentists. Support Care Cancer 2015;23:13-9. [DOI: 10.1007/s00520-014-2297-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
149 Mori Y, Teshima T, Kamezaki K, Kato K, Takenaka K, Iwasaki H, Miyamoto T, Nagafuji K, Eto T, Akashi K. Validation of pretransplantation assessment of mortality risk score in the outcome of hematopoietic SCT in non-Caucasians. Bone Marrow Transplant 2012;47:1075-81. [DOI: 10.1038/bmt.2011.229] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
150 Espigado I, Ortega-Ortega M, Montero-Granados R, Rodriguez-Torres N, Márquez-Malaver FJ. Differences in stem cell transplantation activity among regions in Spain: an economic explanation. Bone Marrow Transplant 2016;51:1537-9. [PMID: 27376450 DOI: 10.1038/bmt.2016.177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
151 Clark CA, Savani M, Mohty M, Savani BN. What do we need to know about allogeneic hematopoietic stem cell transplant survivors? Bone Marrow Transplant 2016;51:1025-31. [PMID: 27064688 DOI: 10.1038/bmt.2016.95] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
152 Zhou XY, Zhu FM, Li JP, Mao W, Zhang DM, Liu ML, Hei AL, Dai DP, Jiang P, Shan XY, Zhang BW, Zhu CF, Shen J, Deng ZH, Wang ZL, Yu WJ, Chen Q, Qiao YH, Zhu XM, Lv R, Li GY, Li GL, Li HC, Zhang X, Pei B, Jiao LX, Shen G, Liu Y, Feng ZH, Su YP, Xu ZX, Di WY, Jiang YQ, Fu HL, Liu XJ, Liu X, Zhou MZ, Du D, Liu Q, Han Y, Zhang ZX, Cai JP. High-Resolution Analyses of Human Leukocyte Antigens Allele and Haplotype Frequencies Based on 169,995 Volunteers from the China Bone Marrow Donor Registry Program. PLoS One 2015;10:e0139485. [PMID: 26421847 DOI: 10.1371/journal.pone.0139485] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
153 Singh M. Pediatrics in 21st Century and Beyond. Indian J Pediatr 2016;83:1420-5. [PMID: 27510612 DOI: 10.1007/s12098-016-2206-z] [Reference Citation Analysis]
154 Cowan AJ, Baldomero H, Atsuta Y, Mikhael J, Aljurf M, Seber A, Greinix H, Koh M, Worel N, Libby EN, Pasquini M, Galeano S, Saber W, Iida M, Jaimovich G, Rolon JM, Kodera Y, Benakli M, Nosa BG, Elhaddad A, Szer J, Passweg J, Kroeger N, Weisdorf D, Niederwieser D. The Global State of Hematopoietic Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation Database and the Global Burden of Disease Study. Biol Blood Marrow Transplant 2020;26:2372-7. [PMID: 32846200 DOI: 10.1016/j.bbmt.2020.08.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Frankiewicz A, Peczynski C, Giebel S, Harrington A, Socié G, Niederwieser D, Scheid C, Bornhäuser M, Kröger N, Elmaagacli A, Afanasyev B, Dreger P, Rössig C, Blaise D, Kratz C, Yakoub-Agha I, Kremens B, Niemeyer CM, Wulf G, Blau I, Penack O, Greinix H, Basak GW. Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMT. Front Immunol 2020;11:1537. [PMID: 32793210 DOI: 10.3389/fimmu.2020.01537] [Reference Citation Analysis]
156 Mauramo M, Rohde L, Ramseier AM, Rovó A, Waltimo T. Determinants of stimulated salivary flow among haematopoietic stem cell transplantation recipients. Clin Oral Investig 2017;21:121-6. [PMID: 26911494 DOI: 10.1007/s00784-016-1760-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
157 Säwén P, Lang S, Mandal P, Rossi DJ, Soneji S, Bryder D. Mitotic History Reveals Distinct Stem Cell Populations and Their Contributions to Hematopoiesis. Cell Rep 2016;14:2809-18. [PMID: 26997272 DOI: 10.1016/j.celrep.2016.02.073] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
158 Kim WH, Jung DW, Williams DR. Making cardiomyocytes with your chemistry set: Small molecule-induced cardiogenesis in somatic cells. World J Cardiol 2015; 7(3): 125-133 [PMID: 25810812 DOI: 10.4330/wjc.v7.i3.125] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
159 Chen C, Guderyon MJ, Ge G, Clark RA, Li S. Lentiviral Infection of Mouse Bone Marrow Cells for Hematopoietic Stem Cell Transplantation. Methods Mol Biol 2019;1919:205-13. [PMID: 30656632 DOI: 10.1007/978-1-4939-9007-8_16] [Reference Citation Analysis]
160 Fattinger N, Roth JA, Baldomero H, Stolz D, Medinger M, Heim D, Tamm M, Halter JP, Passweg JR, Kleber M. External Validation of the Revised Pretransplant Assessment of Mortality Score in Allogeneic Hematopoietic Cell Transplantation: A Cohort Study. HemaSphere 2022;6:e704. [DOI: 10.1097/hs9.0000000000000704] [Reference Citation Analysis]
161 Keusch F, Rao R, Chang L, Lepkowski J, Reddy P, Choi SW. Participation in clinical research: perspectives of adult patients and parents of pediatric patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014;20:1604-11. [PMID: 24972252 DOI: 10.1016/j.bbmt.2014.06.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
162 Wang K, Lv M, Chang YJ, Zhao XY, Zhao XS, Zhang YY, Sun YQ, Wang ZD, Suo P, Zhou Y, Liu D, Zhai SZ, Hong Y, Wang Y, Zhang XH, Xu LP, Liu KY, Huang XJ. Early myeloid-derived suppressor cells (HLA-DR-/lowCD33+CD16-) expanded by granulocyte colony-stimulating factor prevent acute graft-versus-host disease (GVHD) in humanized mouse and might contribute to lower GVHD in patients post allo-HSCT. J Hematol Oncol 2019;12:31. [PMID: 30885244 DOI: 10.1186/s13045-019-0710-0] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
163 Sinatora F, Traverso A, Zanato S, Di Florio N, Porreca A, Tremolada M, Boscolo V, Marzollo A, Mainardi C, Calore E, Pillon M, Cattelan C, Basso G, Messina C. Quality of Life and Psychopathology in Adults Who Underwent Hematopoietic Stem Cell Transplantation (HSCT) in Childhood: A Qualitative and Quantitative Analysis. Front Psychol 2017;8:1316. [PMID: 28848462 DOI: 10.3389/fpsyg.2017.01316] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
164 Braga-Diniz JM, Santa-Rosa CC, Martins RC, Silva MESE, Vieira LQ, Ribeiro Sobrinho AP. The need for endodontic treatment and systemic characteristics of hematopoietic stem cell transplantation patients. Braz Oral Res 2017;31:e50. [PMID: 28678969 DOI: 10.1590/1807-3107BOR-2017.vol31.0050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
165 Bao W, Zhang Q, Zheng H, Li L, Liu M, Cheng H, Wong T, Zhang G, Lu A, Bian Z, Ma D, Leung C, Han Q. Radix Astragali polysaccharide RAP directly protects hematopoietic stem cells from chemotherapy-induced myelosuppression by increasing FOS expression. Int J Biol Macromol 2021;183:1715-22. [PMID: 34044030 DOI: 10.1016/j.ijbiomac.2021.05.120] [Reference Citation Analysis]
166 El-Jawahri A, Jacobs JM, Nelson AM, Traeger L, Greer JA, Nicholson S, Waldman LP, Fenech AL, Jagielo AD, D'Alotto J, Horick N, Spitzer T, DeFilipp Z, Chen YA, Temel JS. Multimodal psychosocial intervention for family caregivers of patients undergoing hematopoietic stem cell transplantation: A randomized clinical trial. Cancer 2020;126:1758-65. [PMID: 31899552 DOI: 10.1002/cncr.32680] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
167 Alaloul F, Brockopp DY, Andrykowski MA, Hall LA, Al Nusairat TS. Quality of life in Arab Muslim cancer survivors following hematopoietic stem cell transplantation: comparison with matched healthy group. Support Care Cancer 2015;23:2157-64. [PMID: 25556704 DOI: 10.1007/s00520-014-2583-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
168 Cottle C, Porter AP, Lipat A, Turner-Lyles C, Nguyen J, Moll G, Chinnadurai R. Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal/Stem Cells and Other Common Cellular Therapeutics. Curr Stem Cell Rep 2022;:1-21. [PMID: 35502223 DOI: 10.1007/s40778-022-00212-1] [Reference Citation Analysis]
169 Ghavamzadeh A, Alimoghaddam K, Ghaffari F, Derakhshandeh R, Jalali A, Jahani M. Twenty years of experience on stem cell transplantation in iran. Iran Red Crescent Med J 2013;15:93-100. [PMID: 23682320 DOI: 10.5812/ircmj.1915] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
170 Morton C, Puchalski J. The utility of bronchoscopy in immunocompromised patients: a review. J Thorac Dis 2019;11:5603-12. [PMID: 32030281 DOI: 10.21037/jtd.2019.09.72] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
171 Carnot Uria J, Hernández Cruz C, Muñío Perurena J, Torres Yribar W, Diego de la Campa J, Del Castillo Carrillo C, Rodríguez Fraga Y, López Silva JA, Cepero Llauger K, Pardo Ramírez IK, García García A, Sweiss K, Patel PR, Rondelli D. Bone Marrow Transplantation in Patients With Acute Leukemia In Cuba: Results From the Last 30 Years and New Opportunities Through International Collaboration. J Glob Oncol 2018;4:1-7. [PMID: 30582434 DOI: 10.1200/JGO.18.00109] [Reference Citation Analysis]
172 Socié G, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR, Volin L, Ruutu T, Heim DA, Schwerdtfeger R. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood. 2011;117:6375-6382. [PMID: 21467544 DOI: 10.1182/blood-2011-01-329821] [Cited by in Crossref: 215] [Cited by in F6Publishing: 204] [Article Influence: 19.5] [Reference Citation Analysis]
173 Verma SK, Goswami GK. DNA evidence: Current perspective and future challenges in India. Forensic Science International 2014;241:183-9. [DOI: 10.1016/j.forsciint.2014.05.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
174 Sheldon LK, Kazmi M, Klein C, Berry DL. Concerns of stem cell transplant patients during routine ambulatory assessment. Patient Prefer Adherence. 2013;7:15-20. [PMID: 23319854 DOI: 10.2147/ppa.s38567] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
175 Gratwohl A, Pasquini MC, Aljurf M, Atsuta Y, Baldomero H, Foeken L, Gratwohl M, Bouzas LF, Confer D, Frauendorfer K, Gluckman E, Greinix H, Horowitz M, Iida M, Lipton J, Madrigal A, Mohty M, Noel L, Novitzky N, Nunez J, Oudshoorn M, Passweg J, van Rood J, Szer J, Blume K, Appelbaum FR, Kodera Y, Niederwieser D;  Worldwide Network for Blood and Marrow Transplantation (WBMT). One million haemopoietic stem-cell transplants: a retrospective observational study. Lancet Haematol. 2015;2:e91-100. [PMID: 26687803 DOI: 10.1016/s2352-3026(15)00028-9] [Cited by in Crossref: 222] [Cited by in F6Publishing: 99] [Article Influence: 31.7] [Reference Citation Analysis]
176 Hutt D, Nehari M, Munitz-shenkar D, Alkalay Y, Toren A, Bielorai B. Hematopoietic stem cell donation: psychological perspectives of pediatric sibling donors and their parents. Bone Marrow Transplant 2015;50:1337-42. [DOI: 10.1038/bmt.2015.152] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
177 Daikeler T, Mauramo M, Rovó A, Stern M, Halter J, Buser A, Tyndall A, Häusermann P, Gratwohl A, Tichelli A, Brennan MT, Waltimo T. Sicca symptoms and their impact on quality of life among very long-term survivors after hematopoietic SCT. Bone Marrow Transplant 2013;48:988-93. [PMID: 23292241 DOI: 10.1038/bmt.2012.260] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
178 Faulkner L, Verna M, Rovelli A, Agarwal RK, Dhanya R, Parmar L, Sedai A, Kumari A, Ramprakash S, Raghuram CP, Mehta P, Elizabeth S, Khalid S, Batool A, Ghilani SK, Fatima I, Zara T, Marwah P, Soni R, Trivedi D, Conter V, Canesi M, Othman D, Faeq V, Kleinschmidt K, Yesillipek A, Lam CG, Howard SC, Corbacioglu S; Pediatric Diseases Working Party of the European Blood and Marrow Transplantation Group. Setting up and sustaining blood and marrow transplant services for children in middle-income economies: an experience-driven position paper on behalf of the EBMT PDWP. Bone Marrow Transplant 2021;56:536-43. [PMID: 32893265 DOI: 10.1038/s41409-020-0983-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
179 Østgård LSG, Lund JL, Nørgaard JM, Nørgaard M, Medeiros BC, Nielsen B, Nielsen OJ, Overgaard UM, Kallenbach M, Marcher CW, Riis AH, Sengeløv H. Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study. Biol Blood Marrow Transplant 2018;24:314-23. [PMID: 29051022 DOI: 10.1016/j.bbmt.2017.10.019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
180 Gratwohl A, Iacobelli S, Bootsman N, van Biezen A, Baldomero H, Arcese W, Arnold R, Bron D, Cordonnier C, Ernst P, Ferrant A, Frassoni F, Gahrton G, Richard C, Kolb HJ, Link H, Niederwieser D, Ruutu T, Schattenberg A, Schmitz N, Torres-gomez A, Zwaan F, Apperley J, Olavarria E, Kröger N; for the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation EBMT. Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized study. Ann Hematol 2016;95:967-72. [DOI: 10.1007/s00277-016-2638-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
181 Persoon S, Kersten MJ, van der Weiden K, Buffart LM, Nollet F, Brug J, Chinapaw MJ. Effects of exercise in patients treated with stem cell transplantation for a hematologic malignancy: A systematic review and meta-analysis. Cancer Treatment Reviews 2013;39:682-90. [DOI: 10.1016/j.ctrv.2013.01.001] [Cited by in Crossref: 92] [Cited by in F6Publishing: 81] [Article Influence: 10.2] [Reference Citation Analysis]
182 Savani BN. How Can We Improve Life Expectancy and Quality of Life in Long-Term Survivors After Allogeneic Stem Cell Transplantation? Seminars in Hematology 2012;49:1-3. [DOI: 10.1053/j.seminhematol.2011.10.014] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
183 Fiuza-Luces C, Soares-Miranda L, González-Murillo A, Palacio JM, Colmenero I, Casco F, Melén GJ, Delmiro A, Morán M, Ramírez M, Lucia A. Exercise benefits in chronic graft versus host disease: a murine model study. Med Sci Sports Exerc 2013;45:1703-11. [PMID: 23954992 DOI: 10.1249/MSS.0b013e31828fa004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
184 Ahmed SO, El Fakih R, Elhaddad A, Ali Hamidieh A, Altbakhi A, Chaudhry QU, Bazarbachi A, Adil S, Al-Khabori M, Ben Othman T, Gaziev J, Khalaf M, Alshammeri S, Alotaibi S, Alshahrani M, Bekadja MA, Ibrahim A, Al-Wahadneh AM, Altarshi M, Alsaeed A, Madani A, Abboud M, Abujazar H, Bakr M, Abosoudah I, El Cheikh J, Almasari A, Alfraih F, Baldomero H, Elsolh H, Niederwieser D, Chaudhri N, Aljurf M. Strategic priorities for hematopoietic stem cell transplantation in the EMRO region. Hematol Oncol Stem Cell Ther 2021:S1658-3876(21)00090-X. [PMID: 34688625 DOI: 10.1016/j.hemonc.2021.09.006] [Reference Citation Analysis]
185 Espinoza JL, Kamio K, Lam VQ, Takami A. The Impact of NLRP3 Activation on Hematopoietic Stem Cell Transplantation. Int J Mol Sci 2021;22:11845. [PMID: 34769275 DOI: 10.3390/ijms222111845] [Reference Citation Analysis]
186 Chabannon C, Pamphilon D, Vermylen C, Gratwohl A, Niederwieser D, Mcgrath E, Lamers C, Lanza F, Slaper-cortenbach I, Madrigal A, Apperley J. Ten years after the first inspection of a candidate European centre, an EBMT registry analysis suggests that clinical outcome is improved when hematopoietic SCT is performed in a JACIE accredited program. Bone Marrow Transplant 2012;47:15-7. [DOI: 10.1038/bmt.2011.32] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
187 Niederwieser D, Baldomero H, Szer J, Gratwohl M, Aljurf M, Atsuta Y, Bouzas LF, Confer D, Greinix H, Horowitz M. Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global survey. Bone Marrow Transplant. 2016;51:778-785. [PMID: 26901703 DOI: 10.1038/bmt.2016.18] [Cited by in Crossref: 185] [Cited by in F6Publishing: 160] [Article Influence: 30.8] [Reference Citation Analysis]
188 Abasaeed R, Coldwell SE, Lloid ME, Soliman SH, Macris PC, Schubert MM. Chemosensory changes and quality of life in patients undergoing hematopoietic stem cell transplantation. Support Care Cancer 2018;26:3553-61. [PMID: 29704111 DOI: 10.1007/s00520-018-4200-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
189 Pulsipher MA, Logan BR, Kiefer DM, Chitphakdithai P, Riches ML, Rizzo JD, Anderlini P, Leitman OF, Kobusingye H, Besser RM, Miller JP, Drexler RJ, Abdel-Mageed A, Ahmed IA, Akard LP, Artz AS, Ball ED, Bayer RL, Bigelow C, Bolwell BJ, Broun ER, Delgado DC, Duckworth K, Dvorak CC, Hahn TE, Haight AE, Hari PN, Hayes-Lattin BM, Jacobsohn DA, Jakubowski AA, Kasow KA, Lazarus HM, Liesveld JL, Linenberger M, Litzow MR, Longo W, Magalhaes-Silverman M, McCarty JM, McGuirk JP, Mori S, Parameswaran V, Prasad VK, Rowley SD, Rybka WB, Sahdev I, Schriber JR, Selby GB, Shaughnessy PJ, Shenoy S, Spitzer T, Tse WT, Uberti JP, Vusirikala M, Waller EK, Weisdorf DJ, Yanik GA, Navarro WH, Horowitz MM, Switzer GE, Confer DL, Shaw BE. Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors. Haematologica 2019;104:844-54. [PMID: 30381298 DOI: 10.3324/haematol.2018.200121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
190 José RJ, Dickey BF, Sheshadri A. Airway disease in hematologic malignancies. Expert Rev Respir Med 2022. [PMID: 35176948 DOI: 10.1080/17476348.2022.2043746] [Reference Citation Analysis]
191 Atsuta Y, Kanda J, Takanashi M, Morishima Y, Taniguchi S, Takahashi S, Ogawa H, Ohashi K, Ohno Y, Onishi Y, Aotsuka N, Nagamura-Inoue T, Kato K, Kanda Y; HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Different effects of HLA disparity on transplant outcomes after single-unit cord blood transplantation between pediatric and adult patients with leukemia. Haematologica 2013;98:814-22. [PMID: 23349300 DOI: 10.3324/haematol.2012.076042] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
192 Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2014:CD010983. [PMID: 25722651 DOI: 10.1002/14651858.CD010983] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
193 Ferrara F, Izzo T, Criscuolo C, Riccardi C, Viola A, Delia R, Carbone A, Celentano M. Comparison of fixed dose pegfilgrastim and daily filgrastim after autologous stem cell transplantation in patients with multiple myeloma autografted on a outpatient basis. Hematol Oncol 2011;29:139-43. [PMID: 21922508 DOI: 10.1002/hon.978] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
194 Passweg JR, Baldomero H, Chabannon C, Corbacioglu S, de la Cámara R, Dolstra H, Glass B, Greco R, Mohty M, Neven B, Peffault de Latour R, Perić Z, Snowden JA, Yakoub-Agha I, Sureda A, Kröger N; European Society for Blood and Marrow Transplantation (EBMT). Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey. Bone Marrow Transplant 2022. [PMID: 35194156 DOI: 10.1038/s41409-022-01604-x] [Reference Citation Analysis]
195 Brozowski JM, Billard MJ, Tarrant TK. Targeting the molecular and cellular interactions of the bone marrow niche in immunologic disease. Curr Allergy Asthma Rep 2014;14:402. [PMID: 24408534 DOI: 10.1007/s11882-013-0402-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
196 Aljurf M, Rizzo JD, Mohty M, Hussain F, Madrigal A, Pasquini MC, Passweg J, Chaudhri N, Ghavamzadeh A, Solh HE, Atsuta Y, Szer J, Kodera Y, Niederweiser D, Gratwohl A, Horowitz MM. Challenges and opportunities for HSCT outcome registries: perspective from international HSCT registries experts. Bone Marrow Transplant 2014;49:1016-21. [DOI: 10.1038/bmt.2014.78] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
197 Sharma Poudyal B, Gyawali B, Tuladhar S, Kapali K, Shrestha GS. Inspiration amidst the challenges: the first report of successful bone marrow transplantation in the Himalayan country Nepal. Br J Haematol 2016;173:941-2. [PMID: 26303869 DOI: 10.1111/bjh.13645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
198 Pineault N, Abu-khader A. Advances in umbilical cord blood stem cell expansion and clinical translation. Experimental Hematology 2015;43:498-513. [DOI: 10.1016/j.exphem.2015.04.011] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 11.4] [Reference Citation Analysis]
199 Snowden JA, Badoglio M, Labopin M, Giebel S, McGrath E, Marjanovic Z, Burman J, Moore J, Rovira M, Wulffraat NM, Kazmi M, Greco R, Snarski E, Kozak T, Kirgizov K, Alexander T, Bader P, Saccardi R, Farge D; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP); EBMT Paediatric Working Party (PWP); Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT); EBMT (JACIE). Evolution, trends, outcomes, and economics of hematopoietic stem cell transplantation in severe autoimmune diseases. Blood Adv. 2017;1:2742-2755. [PMID: 29296926 DOI: 10.1182/bloodadvances.2017010041] [Cited by in Crossref: 96] [Cited by in F6Publishing: 84] [Article Influence: 19.2] [Reference Citation Analysis]
200 Domingo-Gonzalez R, Moore BB. Defective pulmonary innate immune responses post-stem cell transplantation; review and results from one model system. Front Immunol 2013;4:126. [PMID: 23745124 DOI: 10.3389/fimmu.2013.00126] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
201 Huang W, Chao NJ. Memory T cells: A helpful guard for allogeneic hematopoietic stem cell transplantation without causing graft-versus-host disease. Hematol Oncol Stem Cell Ther 2017;10:211-9. [PMID: 28636890 DOI: 10.1016/j.hemonc.2017.05.006] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
202 Lee J, Shieh JH, Zhang J, Liu L, Zhang Y, Eom JY, Morrone G, Moore MA, Zhou P. Improved ex vivo expansion of adult hematopoietic stem cells by overcoming CUL4-mediated degradation of HOXB4. Blood 2013;121:4082-9. [PMID: 23520338 DOI: 10.1182/blood-2012-09-455204] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
203 Lin S, Zhao R, Xiao Y, Li P. Mechanisms determining the fate of hematopoietic stem cells. Stem Cell Investig 2015;2:10. [PMID: 27358878 DOI: 10.3978/j.issn.2306-9759.2015.05.01] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
204 Servais S, Beguin Y, Baron F. Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Emerging Drugs 2013;18:173-92. [DOI: 10.1517/14728214.2013.798642] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
205 Chakraborty R, Savani BN, Litzow M, Mohty M, Hashmi S. A perspective on complementary/alternative medicine use among survivors of hematopoietic stem cell transplant: Benefits and uncertainties. Cancer 2015;121:2303-13. [PMID: 25872879 DOI: 10.1002/cncr.29382] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
206 Spólnicka M, Pośpiech E, Pepłońska B, Zbieć-Piekarska R, Makowska Ż, Pięta A, Karłowska-Pik J, Ziemkiewicz B, Wężyk M, Gasperowicz P, Bednarczuk T, Barcikowska M, Żekanowski C, Płoski R, Branicki W. DNA methylation in ELOVL2 and C1orf132 correctly predicted chronological age of individuals from three disease groups. Int J Legal Med 2018;132:1-11. [PMID: 28725932 DOI: 10.1007/s00414-017-1636-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 7.4] [Reference Citation Analysis]
207 Oliveira GH, Al-Kindi SG, Guha A, Dey AK, Rhea IB, deLima MJ. Cardiovascular risk assessment and management of patients undergoing hematopoietic cell transplantation. Bone Marrow Transplant 2021;56:544-51. [PMID: 33130819 DOI: 10.1038/s41409-020-01080-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
208 Passweg JR, Baldomero H, Bader P, Basak GW, Bonini C, Duarte R, Dufour C, Kröger N, Kuball J, Lankester A, Montoto S, Nagler A, Snowden JA, Styczynski J, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Is the use of unrelated donor transplantation leveling off in Europe? The 2016 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2018;53:1139-48. [PMID: 29540849 DOI: 10.1038/s41409-018-0153-1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 19.3] [Reference Citation Analysis]
209 Lucena CM, Torres A, Rovira M, Marcos MA, de la Bellacasa JP, Sánchez M, Domingo R, Gabarrus A, Mensa J, Agustí C. Pulmonary complications in hematopoietic SCT: a prospective study. Bone Marrow Transplant 2014;49:1293-9. [PMID: 25046219 DOI: 10.1038/bmt.2014.151] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
210 Hsing DD, Howell JD, Greenwald BM. The critically ill pediatric hematopoietic stem cell transplant patient: what have we learned? Pediatr Crit Care Med 2013;14:326-8. [PMID: 23462355 DOI: 10.1097/PCC.0b013e31827d0e46] [Reference Citation Analysis]
211 Conrad A, Perry M, Langlois ME, Labussière-Wallet H, Barraco F, Ducastelle-Leprêtre S, Larcher MV, Balsat M, Boccard M, Chidiac C, Ferry T, Roure-Sobas C, Salles G, Valour F, Ader F; Lyon HemInf Study Group. Efficacy and Safety of Revaccination against Tetanus, Diphtheria, Haemophilus influenzae Type b and Hepatitis B Virus in a Prospective Cohort of Adult Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:1729-37. [PMID: 32428736 DOI: 10.1016/j.bbmt.2020.05.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
212 Shin JW, Swift J, Ivanovska I, Spinler KR, Buxboim A, Discher DE. Mechanobiology of bone marrow stem cells: from myosin-II forces to compliance of matrix and nucleus in cell forms and fates. Differentiation 2013;86:77-86. [PMID: 23790394 DOI: 10.1016/j.diff.2013.05.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
213 Marinelli T, Wee LYA, Rowe E, Chhetri R, Friel O, Higgins G, Bardy P, Singhal D, Pradhan A, Crawford L, Hiwase DK. Respiratory Viruses Cause Late Morbidity in Recipients of Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:782-8. [PMID: 31866345 DOI: 10.1016/j.bbmt.2019.12.724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
214 Halagan M, Manor S, Shriki N, Yaniv I, Zisser B, Madbouly A, Maiers M, Stein J. East Meets West-Impact of Ethnicity on Donor Match Rates in the Ezer Mizion Bone Marrow Donor Registry. Biol Blood Marrow Transplant 2017;23:1381-6. [PMID: 28396163 DOI: 10.1016/j.bbmt.2017.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
215 Passweg JR, Baldomero H, Gratwohl A, Bregni M, Cesaro S, Dreger P, de Witte T, Farge-Bancel D, Gaspar B, Marsh J, Mohty M, Peters C, Tichelli A, Velardi A, de Elvira CR, Falkenburg F, Sureda A, Madrigal A; European Group for Blood and Marrow Transplantation (EBMT). The EBMT activity survey: 1990-2010. Bone Marrow Transplant 2012;47:906-23. [PMID: 22543746 DOI: 10.1038/bmt.2012.66] [Cited by in Crossref: 141] [Cited by in F6Publishing: 133] [Article Influence: 14.1] [Reference Citation Analysis]
216 Shima T, Forraz N, Sato N, Yamauchi T, Iwasaki H, Takenaka K, Akashi K, Mcguckin C, Teshima T. A novel filtration method for cord blood processing using a polyester fabric filter. Int Jnl Lab Hem 2013;35:436-46. [DOI: 10.1111/ijlh.12039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
217 Saruta H, Ohata C, Muto I, Imamura T, Oku E, Ohshima K, Nagafuji K, Nakama T. Hematopoietic stem cell transplantation in advanced cutaneous T-cell lymphoma. J Dermatol 2017;44:1038-42. [PMID: 28391645 DOI: 10.1111/1346-8138.13848] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
218 Fernandes SR, Alves AT, Cortes MB, Cortez-Pinto H. Graft-versus-host disease: unexpected presentation with simultaneous hepatitis and pancreatitis. BMJ Case Rep 2016;2016:bcr2016215940. [PMID: 27485875 DOI: 10.1136/bcr-2016-215940] [Reference Citation Analysis]
219 Csaszar E, Cohen S, Zandstra PW. Blood stem cell products: Toward sustainable benchmarks for clinical translation. Bioessays 2013;35:201-10. [DOI: 10.1002/bies.201200118] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
220 Bahoush G. Outcome of Patients Treated with Hematopoietic Stem Cell Transplantation: Results from A Single Center. Asia Pac J Oncol Nurs 2021;8:218-23. [PMID: 33688572 DOI: 10.4103/apjon.apjon_55_20] [Reference Citation Analysis]
221 Ting CY, Lee YF, Lim CJ, Ting RSK, Md Zahrin MM, Ahmad AS, Wong JSY, Arip M, Zakaria Z, Ahmad Zaidi Adruce S, Tnay JKS, Wong YS. Factors Associated with Intention to Donate Hematopoietic Stem Cells among Blood Donors. Transfus Med Hemother 2021;48:188-95. [PMID: 34177425 DOI: 10.1159/000512197] [Reference Citation Analysis]
222 Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Kuball J, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant 2016;51:786-92. [PMID: 26901709 DOI: 10.1038/bmt.2016.20] [Cited by in Crossref: 228] [Cited by in F6Publishing: 217] [Article Influence: 38.0] [Reference Citation Analysis]
223 Arulmozhivarman G, Stöter M, Bickle M, Kräter M, Wobus M, Ehninger G, Stölzel F, Brand M, Bornhäuser M, Shayegi N. In Vivo Chemical Screen in Zebrafish Embryos Identifies Regulators of Hematopoiesis Using a Semiautomated Imaging Assay. J Biomol Screen 2016;21:956-64. [DOI: 10.1177/1087057116644163] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
224 Espinoza JL, Wadasaki Y, Takami A. Infection Complications in Hematopoietic Stem Cells Transplant Recipients: Do Genetics Really Matter? Front Microbiol 2018;9:2317. [PMID: 30356925 DOI: 10.3389/fmicb.2018.02317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
225 Lachance S, Gomes MM, Bambace NM, Bittencourt H, Lepic K, Shafey M, Karpinski J, Guilcher GMT. Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in Canada. Transplant Cell Ther 2021:S2666-6367(21)00997-0. [PMID: 34153503 DOI: 10.1016/j.jtct.2021.06.013] [Reference Citation Analysis]
226 Gratwohl A, Baldomero H, Passweg J. Hematopoietic stem cell transplantation activity in Europe: . Current Opinion in Hematology 2013;20:485-93. [DOI: 10.1097/moh.0b013e328364f573] [Cited by in Crossref: 42] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
227 Atsuta Y, Suzuki R, Yamashita T, Fukuda T, Miyamura K, Taniguchi S, Iida H, Uchida T, Ikegame K, Takahashi S. Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease. Ann Oncol. 2014;25:435-441. [PMID: 24399081 DOI: 10.1093/annonc/mdt558] [Cited by in Crossref: 60] [Cited by in F6Publishing: 51] [Article Influence: 7.5] [Reference Citation Analysis]
228 Heidegger S, van den Brink MR, Haas T, Poeck H. The role of pattern-recognition receptors in graft-versus-host disease and graft-versus-leukemia after allogeneic stem cell transplantation. Front Immunol 2014;5:337. [PMID: 25101080 DOI: 10.3389/fimmu.2014.00337] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
229 Shah NN, Kucharczuk CR, Mitra N, Hirsh R, Svoboda J, Porter D, Loren A, Frey N, Schapira MM. Implementation of an Advanced Practice Provider Service on an Allogeneic Stem Cell Transplant Unit: Impact on Patient Outcomes. Biology of Blood and Marrow Transplantation 2015;21:1692-8. [DOI: 10.1016/j.bbmt.2015.05.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
230 Kato F, Daiko H, Kanamori J, Inamoto Y, Fukuda T, Hayashi K, Tachimori Y, Koyanagi K. Esophagectomy for the patients with squamous cell carcinoma of the esophagus after allogeneic hematopoietic stem cell transplantation. Int J Clin Oncol 2020;25:82-8. [PMID: 31549271 DOI: 10.1007/s10147-019-01549-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
231 Celluzzi CM, Keever-taylor C, Alurf M, Koh MB, Rabe F, Rebulla P, Sacchi N, Sanders J, Mcgrath E, Loper K; The Alliance for Harmonisation of Cellular Therapy Accreditation (AHCTA). Training practices of hematopoietic progenitor cell-apheresis and -cord blood collection staff: analysis of a survey by the Alliance for Harmonisation of Cellular Therapy Accreditation: HPC Collection Staff Training Practices. Transfusion 2014;54:3138-44. [DOI: 10.1111/trf.12753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
232 Virmani P, Zain J, Rosen ST, Myskowski PL, Querfeld C. Hematopoietic Stem Cell Transplant for Mycosis Fungoides and Sézary Syndrome. Dermatologic Clinics 2015;33:807-18. [DOI: 10.1016/j.det.2015.05.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
233 Muhsen IN, Hashmi SK, Niederwieser D, Kroeger N, Agrawal S, Pasquini MC, Atsuta Y, Ballen KK, Seber A, Saber W, Kharfan-Dabaja MA, Rasheed W, Okamoto S, Khera N, Wood WA, Koh MBC, Greinix H, Kodera Y, Szer J, Horowitz MM, Weisdorf D, Aljurf M. Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries. Bone Marrow Transplant 2020;55:698-707. [PMID: 31484992 DOI: 10.1038/s41409-019-0658-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
234 Rood MT, Spa SJ, Welling MM, Ten Hove JB, van Willigen DM, Buckle T, Velders AH, van Leeuwen FW. Obtaining control of cell surface functionalizations via Pre-targeting and Supramolecular host guest interactions. Sci Rep 2017;7:39908. [PMID: 28057918 DOI: 10.1038/srep39908] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
235 Rueda-Lara M, Lopez-Patton MR. Psychiatric and psychosocial challenges in patients undergoing haematopoietic stem cell transplants. Int Rev Psychiatry 2014;26:74-86. [PMID: 24716502 DOI: 10.3109/09540261.2013.866075] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
236 Jabbour J, Manana B, Sakr M, Zahreddine A, Tamim H, Bazarbachi A, Blaise D, El-Cheikh J. The impact of counseling on nutritional status among hematopoietic stem cell recipients: results of a randomized controlled trial. Bone Marrow Transplant 2019;54:752-6. [PMID: 30349039 DOI: 10.1038/s41409-018-0366-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
237 Adhikari J, Sharma P, Bhatt VR. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies. Future Oncol 2015;11:3175-85. [PMID: 26551415 DOI: 10.2217/fon.15.252] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
238 Rangarajan HG, Smith LC, Stanek JR, Hall M, Abu-arja R, Auletta JJ, O'brien SH. Increased Health Care Utilization and Costs during Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndromes in Adolescents and Young Adults Compared with Children: A Multicenter Study. Biology of Blood and Marrow Transplantation 2019;25:1031-8. [DOI: 10.1016/j.bbmt.2019.01.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
239 Tiwari AK, Arora D, Dara RC, Dorwal P, Sood N, Misra R, Gupta SK, Raina V, Vaid AK. Newly established stem cell transplant program: 100 days follow-up of patients and its comparison with published Indian literature. Indian J Med Paediatr Oncol 2016;37:168-73. [PMID: 27688610 DOI: 10.4103/0971-5851.190362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
240 Hwang YM, Bang KS. Health-related quality of life of children and adolescents after hematopoietic stem cell transplantationa. Child Health Nurs Res 2020;26:402-10. [PMID: 35004484 DOI: 10.4094/chnr.2020.26.4.402] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
241 Kirmizitas A, Meiklejohn S, Ciau-Uitz A, Stephenson R, Patient R. Dissecting BMP signaling input into the gene regulatory networks driving specification of the blood stem cell lineage. Proc Natl Acad Sci U S A 2017;114:5814-21. [PMID: 28584091 DOI: 10.1073/pnas.1610615114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
242 Seto WK, Chan TS, Hwang YY, Wong DK, Fung J, Liu KS, Gill H, Lam YF, Lau EHY, Cheung KS, Lie AKW, Lai CL, Kwong YL, Yuen MF. Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study. Hepatology 2017;65:1451-61. [PMID: 28027590 DOI: 10.1002/hep.29022] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 13.0] [Reference Citation Analysis]
243 Allareddy V, Venugopalan SR, Eswaran SV, Rampa S, Anamali S, Nalliah RP, Shin K, Allareddy V, Elangovan S. Important impact of gingival and periodontal conditions on outcomes in SCT recipients. Bone Marrow Transplant 2015;50:604-6. [PMID: 25599170 DOI: 10.1038/bmt.2014.311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
244 Gratwohl A, Baldomero H, Passweg J. The role of hematopoietic stem cell transplantation in chronic myeloid leukemia. Ann Hematol. 2015;94 Suppl 2:S177-S186. [PMID: 25814084 DOI: 10.1007/s00277-015-2313-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
245 Kim S, Kim S, Park Y, Shin AR, Yeom H. Nutritional Intervention for a Patient with Acute Lymphoblastic Leukemia on Allogeneic Peripheral Blood Stem Cell Transplantation. Clin Nutr Res 2018;7:223-8. [PMID: 30079320 DOI: 10.7762/cnr.2018.7.3.223] [Reference Citation Analysis]
246 Truong TH, Pole JD, Bittencourt H, Schechter T, Cuvelier GDE, Paulson K, Rayar M, Mitchell D, Schultz KR, O'Shea D, Barber R, Sung L. Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemia. Pediatr Blood Cancer 2020;67:e28263. [PMID: 32323913 DOI: 10.1002/pbc.28263] [Reference Citation Analysis]
247 Ferreira EE, Guerra DC, Baluz K, de Resende Furtado W, da Silva Bouzas LF. Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study. Rev Bras Hematol Hemoter 2014;36:414-9. [PMID: 25453651 DOI: 10.1016/j.bjhh.2014.07.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
248 Ragbourne SC, Crook MA. Metabolic Syndrome in Long-Term Survivors of Hematopoietic Stem-Cell Transplantation. Clin Lymphoma Myeloma Leuk 2017;17:340-6. [PMID: 28622958 DOI: 10.1016/j.clml.2017.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
249 Daniel MG, Lemischka IR, Moore K. Converting cell fates: generating hematopoietic stem cells de novo via transcription factor reprogramming. Ann N Y Acad Sci 2016;1370:24-35. [PMID: 26748878 DOI: 10.1111/nyas.12989] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
250 Zawilinska B, Kopec J, Szostek S, Piatkowska-Jakubas B, Skotnicki AB, Kosz-Vnenchak M. Lymphotropic herpesvirus DNA detection in patients with active CMV infection - a possible role in the course of CMV infection after hematopoietic stem cell transplantation. Med Sci Monit 2011;17:CR432-441. [PMID: 21804462 DOI: 10.12659/msm.881904] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
251 Saboo US, Amparo F, Shikari H, Jurkunas UV, Dana R. Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease. Graefes Arch Clin Exp Ophthalmol 2015;253:901-7. [PMID: 25619668 DOI: 10.1007/s00417-015-2940-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
252 Worel N. ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation. Transfus Med Hemother 2016;43:3-12. [PMID: 27022317 DOI: 10.1159/000441507] [Cited by in Crossref: 43] [Cited by in F6Publishing: 32] [Article Influence: 6.1] [Reference Citation Analysis]
253 Schmidt AH, Sauter J, Pingel J, Ehninger G. Toward an optimal global stem cell donor recruitment strategy. PLoS One 2014;9:e86605. [PMID: 24497958 DOI: 10.1371/journal.pone.0086605] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
254 Vande Vusse LK, Madtes DK, Bolgiano D, Watkins TR. The association between platelet transfusion and idiopathic pneumonia syndrome is unaffected by platelet product type. Transfusion 2016;56:489-96. [PMID: 26435205 DOI: 10.1111/trf.13361] [Cited by in Crossref: 4] [Article Influence: 0.6] [Reference Citation Analysis]
255 Nivison-Smith I, Bardy P, Dodds AJ, Ma DDF, Aarons D, Tran S, Wilcox L, Szer J. A Review of Hematopoietic Cell Transplantation in Australia and New Zealand, 2005 to 2013. Biol Blood Marrow Transplant 2016;22:284-91. [PMID: 26385524 DOI: 10.1016/j.bbmt.2015.09.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
256 Perlin JR, Sporrij A, Zon LI. Blood on the tracks: hematopoietic stem cell-endothelial cell interactions in homing and engraftment. J Mol Med (Berl) 2017;95:809-19. [PMID: 28702683 DOI: 10.1007/s00109-017-1559-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
257 Tuncer HH, Rana N, Milani C, Darko A, Al-Homsi SA. Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol 2012; 18(16): 1851-1860 [PMID: 22563164 DOI: 10.3748/wjg.v18.i16.1851] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 51] [Article Influence: 6.2] [Reference Citation Analysis]
258 Burns AJ, Thapar N. Neural stem cell therapies for enteric nervous system disorders. Nat Rev Gastroenterol Hepatol 2014;11:317-28. [PMID: 24322895 DOI: 10.1038/nrgastro.2013.226] [Cited by in Crossref: 59] [Cited by in F6Publishing: 51] [Article Influence: 6.6] [Reference Citation Analysis]
259 Lee J, Dykstra B, Spencer JA, Kenney LL, Greiner DL, Shultz LD, Brehm MA, Lin CP, Sackstein R, Rossi DJ. mRNA-mediated glycoengineering ameliorates deficient homing of human stem cell-derived hematopoietic progenitors. J Clin Invest 2017;127:2433-7. [PMID: 28481220 DOI: 10.1172/JCI92030] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
260 Galati PC, Chiarello PG, Simões BP. Variation of resting energy expenditure after the first chemotherapy cycle in acute leukemia patients. Nutrition and Cancer 2015;68:86-93. [DOI: 10.1080/01635581.2016.1115100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
261 Fisler G, Haimed A, Levy CF, Stiles J, Capone CA, Fish JD, Brochstein JA, Taylor MD. Severe Coronavirus Disease 2019 Infection in an Adolescent Patient After Hematopoietic Stem Cell Transplantation. Chest 2020;158:e139-42. [PMID: 33036110 DOI: 10.1016/j.chest.2020.05.579] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
262 Desai A, Zhang Y, Park Y, Dawson DM, Larusch GA, Kasturi L, Wald D, Ready JM, Gerson SL, Markowitz SD. A second-generation 15-PGDH inhibitor promotes bone marrow transplant recovery independently of age, transplant dose and granulocyte colony-stimulating factor support. Haematologica 2018;103:1054-64. [PMID: 29472361 DOI: 10.3324/haematol.2017.178376] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
263 Spring L, Li S, Soiffer RJ, Antin JH, Alyea EP 3rd, Glotzbecker B. Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival. Biol Blood Marrow Transplant 2015;21:509-16. [PMID: 25482866 DOI: 10.1016/j.bbmt.2014.11.682] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
264 Hu Y, Liu N, Zhang P, Pan C, Zhang Y, Tang Y, Deng H, Aimaiti M, Zhang Y, Zhou H, Wu G, Tang Z. Preclinical Studies of Stem Cell Transplantation in Intracerebral Hemorrhage: a Systemic Review and Meta-Analysis. Mol Neurobiol 2016;53:5269-77. [PMID: 26409481 DOI: 10.1007/s12035-015-9441-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
265 Ivanovs A, Medvinsky A. In search of human hematopoietic stem cell identity. Cell Stem Cell 2015;16:5-6. [PMID: 25575075 DOI: 10.1016/j.stem.2014.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
266 Barboza-zanetti MO, Barboza-zanetti AC, Rodrigues-abjaude SA, Pinto-simões B, Leira-pereira LR. Clinical pharmacists’ contributions to hematopoietic stem cell transplantation: A systematic review. J Oncol Pharm Pract 2019;25:423-33. [DOI: 10.1177/1078155218782372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
267 Ciáurriz M, Zabalza A, Beloki L, Mansilla C, Pérez-Valderrama E, Lachén M, Bandrés E, Olavarría E, Ramírez N. The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients. Cell Mol Life Sci. 2015;72:4049-4062. [PMID: 26174234 DOI: 10.1007/s00018-015-1986-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
268 Zhou W, Mahshid SS, Wang W, Vallée-Bélisle A, Zandstra PW, Sargent EH, Kelley SO. Steric Hindrance Assay for Secreted Factors in Stem Cell Culture. ACS Sens 2017;2:495-500. [PMID: 28723184 DOI: 10.1021/acssensors.7b00136] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
269 Nivison-smith I, Milliken S, Dodds AJ, Gottlieb D, Kwan J, Ma DD, Shaw PJ, Tran S, Wilcox L, Szer J. Activity and Capacity Profile of Transplant Physicians and Centers in Australia and New Zealand. Biology of Blood and Marrow Transplantation 2018;24:169-74. [DOI: 10.1016/j.bbmt.2017.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
270 Kis B, Pamarthi V, Fan CM, Rabkin D, Baum RA. Safety and utility of transjugular liver biopsy in hematopoietic stem cell transplant recipients. J Vasc Interv Radiol 2013;24:85-9. [PMID: 23200125 DOI: 10.1016/j.jvir.2012.09.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
271 Bubela T, McCabe C, Archibald P, Atkins H, Bradshaw SE, Kefalas P, Mujoomdar M, Packer C, Piret J, Raxworthy M, Soares M, Viswanathan S. Bringing regenerative medicines to the clinic: the future for regulation and reimbursement. Regen Med 2015;10:897-911. [PMID: 26565607 DOI: 10.2217/rme.15.51] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
272 El Fakih R, Greinix H, Koh M, Shaw B, Mohty M, Al Nahedh M, Saber W, Kharfan-Dabaja MA, Perales MA, Savani BN, Majhail NS, Passweg JR, Sureda A, Ahmed SO, Gluckman E, Riches M, El-Jawahri A, Rondelli D, Srivastava A, Faulkner L, Atsuta Y, Ballen KK, Rasheed W, Okamoto S, Seber A, Chao N, Kröger N, Kodera Y, Szer J, Hashmi SK, Horowitz MM, Weisdorf D, Niederwieser D, Aljurf M. Worldwide Network for Blood and Marrow Transplantation (WBMT) Recommendations Regarding Essential Medications Required To Establish An Early Stage Hematopoietic Cell Transplantation Program. Transplant Cell Ther 2021;27:267.e1-5. [PMID: 33781535 DOI: 10.1016/j.jtct.2020.12.015] [Reference Citation Analysis]
273 Singh VK, Singh PK, Wise SY, Seed TM. Mobilized progenitor cells as a bridging therapy for radiation casualties: A brief review of tocopherol succinate-based approaches. International Immunopharmacology 2011;11:842-7. [DOI: 10.1016/j.intimp.2011.01.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
274 Saillard C, Darmon M, Bisbal M, Sannini A, Chow-chine L, Faucher M, Lengline E, Vey N, Blaise D, Azoulay E, Mokart D; on behalf the Groupe de Recherche en Réanimation Respiratoire du patient d’Onco-Hématologie (GRRR-OH). Critically ill allogenic HSCT patients in the intensive care unit: a systematic review and meta-analysis of prognostic factors of mortality. Bone Marrow Transplant 2018;53:1233-41. [DOI: 10.1038/s41409-018-0181-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 5.5] [Reference Citation Analysis]
275 Poudyal BS, Tuladhar S, Neupane S, Sapkota S, Pandit S, Shrestha PR, Poudel B, Bajaracharya M, Sweiss K, Patel P, Mahmud N, Rondelli D. Hematopoietic Stem Cell Transplantation in Nepal: international partnership, implementation steps and clinical outcomes. Transplant Cell Ther 2022:S2666-6367(22)00090-2. [PMID: 35182794 DOI: 10.1016/j.jtct.2022.02.011] [Reference Citation Analysis]
276 Kapadia M, Lehmann L, Auletta J, Beatty L, Bhatt N, Blacken R, Demmel K, Dodd T, Desmond C, Fitch T, Flesch L, Hartley D, Huber J, Ingraham H, Jakubowski R, Klunk A, Krupski C, Kusnier K, Liberio N, Maakaron J, Mueller M, Myers KC, Pai A, Parker L, Patel S, Phelan R, Polishchuk V, Sigmund A, Sper C, Tarquini S, Juckett M, Jaglowski S, Dandoy C, Rotz S. Quality Improvement in Hematopoietic Stem Cell Transplant and Cellular Therapy: Using the Model for Improvement to impact Outcomes. Transplant Cell Ther 2022:S2666-6367(22)00060-4. [PMID: 35151937 DOI: 10.1016/j.jtct.2022.02.003] [Reference Citation Analysis]
277 Gopal S, Wood WA, Lee SJ, Shea TC, Naresh KN, Kazembe PN, Casper C, Hesseling PB, Mitsuyasu RT. Meeting the challenge of hematologic malignancies in sub-Saharan Africa. Blood 2012;119:5078-87. [PMID: 22461494 DOI: 10.1182/blood-2012-02-387092] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 5.5] [Reference Citation Analysis]
278 Bourgeois W, Ricci A, Jin Z, Hall M, George D, Bhatia M, Garvin J, Satwani P. Health care utilization and cost among pediatric patients receiving unrelated donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2019;54:691-9. [DOI: 10.1038/s41409-018-0308-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
279 Pasquini MC, Srivastava A, Ahmed SO, Aljurf M, Atsuta Y, Doleysh C, Galeano S, Gluckman E, Greinix H, Hale G, Hari P, Hashmi SK, Kamani N, Laughlin MJ, Niederwieser D, Seber A, Szer J, Snowden JA, Van Biesen K, Watry P, Weisdorf DJ, Apperley J. Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond. Hematol Oncol Stem Cell Ther 2020;13:131-42. [PMID: 31449780 DOI: 10.1016/j.hemonc.2019.08.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
280 Bauk K, D'Auria JP, Andrews A, Presler CM. The pediatric sibling donor experience in hematopoietic stem cell transplant: an integrative review of the literature. J Pediatr Nurs 2013;28:235-42. [PMID: 23122760 DOI: 10.1016/j.pedn.2012.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
281 Varagnolo L, Lin Q, Obier N, Plass C, Dietl J, Zenke M, Claus R, Müller AM. PRC2 inhibition counteracts the culture-associated loss of engraftment potential of human cord blood-derived hematopoietic stem and progenitor cells. Sci Rep 2015;5:12319. [PMID: 26198814 DOI: 10.1038/srep12319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
282 Lee JM, Kang BW, Han MH, Baek DW. Successful Treatment with High-Dose Chemotherapy Followed by Autologous Stem-Cell Transplantation in a Patient with Metastatic Germ Cell Tumor. Case Rep Oncol 2021;14:998-1003. [PMID: 34326734 DOI: 10.1159/000516755] [Reference Citation Analysis]
283 Ma S, Shi W, Li Z, Tang L, Wang H, Xia L, Hu Y. Reduced-intensity versus Myeloablative Conditioning Regimens for Younger Adults with Acute Myeloid Leukemia and Myelodysplastic Syndrome: A systematic review and meta-analysis. J Cancer 2020;11:5223-35. [PMID: 32742468 DOI: 10.7150/jca.46081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
284 Peled JU, Devlin SM, Staffas A, Lumish M, Khanin R, Littmann ER, Ling L, Kosuri S, Maloy M, Slingerland JB, Ahr KF, Porosnicu Rodriguez KA, Shono Y, Slingerland AE, Docampo MD, Sung AD, Weber D, Alousi AM, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Taur Y, Pamer EG, Jenq RR, van den Brink MRM. Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. J Clin Oncol 2017;35:1650-9. [PMID: 28296584 DOI: 10.1200/JCO.2016.70.3348] [Cited by in Crossref: 141] [Cited by in F6Publishing: 92] [Article Influence: 28.2] [Reference Citation Analysis]
285 Zhou X, Jin N, Chen B. Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation. Oncol Lett 2021;21:318. [PMID: 33692850 DOI: 10.3892/ol.2021.12579] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
286 Preussler JM, Farnia SH, Denzen EM, Majhail NS. Variation in medicaid coverage for hematopoietic cell transplantation. J Oncol Pract 2014;10:e196-200. [PMID: 24715266 DOI: 10.1200/JOP.2013.001155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
287 Zanato S, Traverso A, Tremolada M, Sinatora F, Porreca A, Pozziani G, Di Florio N, Capello F, Marzollo A, Tumino M, Cattelan C, Basso G, Messina C. Psychopathological Aspects in Childhood Hematopoietic Stem Cell Transplantation (HSCT): The Perception of Parents and Adolescents. Front Psychol 2017;8:272. [PMID: 28424633 DOI: 10.3389/fpsyg.2017.00272] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
288 Liu YC, Hsu CM, Hsiao SY, Hsiao HH. Hepatitis B Virus Infection in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation. J Pers Med 2021;11:1108. [PMID: 34834460 DOI: 10.3390/jpm11111108] [Reference Citation Analysis]
289 Halahleh K, Sarhan MM, Peter Gale R, Hashem H, Khattab E, Da'na W, Ma'koseh M, Abu Shanab M, Yousef M, Khalil L, Hussein N, Sharma S, Abujazar H, Rihani R, Tbakhi A, Al Abadi A. Hematopoietic cell transplants in Jordan: different indications from the US and EU. Bone Marrow Transplant 2019;54:1379-81. [PMID: 31150017 DOI: 10.1038/s41409-019-0578-1] [Reference Citation Analysis]
290 Park MY, Lim BG, Kim SY, Sohn HJ, Kim S, Kim TG. GM-CSF Promotes the Expansion and Differentiation of Cord Blood Myeloid-Derived Suppressor Cells, Which Attenuate Xenogeneic Graft-vs.-Host Disease. Front Immunol 2019;10:183. [PMID: 30863394 DOI: 10.3389/fimmu.2019.00183] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
291 Uutela P, Passweg J, Halter J, Weiger R, Waltimo T, Mauramo M. Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre-HSCT. Eur J Haematol 2019;102:351-6. [PMID: 30632215 DOI: 10.1111/ejh.13209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
292 Vertès AA. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: emerging transformational cytotherapies. Regenerative Medicine 2015;10:345-73. [DOI: 10.2217/rme.15.13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
293 Giri J, Moll G. MSCs in Space: Mesenchymal Stromal Cell Therapeutics as Enabling Technology for Long-Distance Manned Space Travel. Curr Stem Cell Rep. [DOI: 10.1007/s40778-022-00207-y] [Reference Citation Analysis]
294 Li MD, Atkins H, Bubela T. The global landscape of stem cell clinical trials. Regen Med. 2014;9:27-39. [PMID: 24236476 DOI: 10.2217/rme.13.80] [Cited by in Crossref: 112] [Cited by in F6Publishing: 85] [Article Influence: 12.4] [Reference Citation Analysis]
295 Ishii T. Somatic Genome Editing for Health: Disease Treatments and Beyond. Curr Stem Cell Rep 2016;2:313-20. [DOI: 10.1007/s40778-016-0061-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
296 Wigmore TJ, Farquhar-Smith P, Lawson A. Intensive care for the cancer patient - unique clinical and ethical challenges and outcome prediction in the critically ill cancer patient. Best Pract Res Clin Anaesthesiol 2013;27:527-43. [PMID: 24267556 DOI: 10.1016/j.bpa.2013.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
297 Desborough M, Estcourt LJ, Doree C, Trivella M, Hopewell S, Stanworth SJ, Murphy MF. Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2016;:CD010982. [PMID: 27548292 DOI: 10.1002/14651858.CD010982.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
298 Atsuta Y, Hirakawa A, Nakasone H, Kurosawa S, Oshima K, Sakai R, Ohashi K, Takahashi S, Mori T, Ozawa Y, Fukuda T, Kanamori H, Morishima Y, Kato K, Yabe H, Sakamaki H, Taniguchi S, Yamashita T; Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation. Late Mortality and Causes of Death among Long-Term Survivors after Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant 2016;22:1702-9. [PMID: 27246369 DOI: 10.1016/j.bbmt.2016.05.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
299 de la Fuente J, Gluckman E, Makani J, Telfer P, Faulkner L, Corbacioglu S; Paediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation. The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing. Lancet Haematol 2020;7:e902-11. [PMID: 33242447 DOI: 10.1016/S2352-3026(20)30283-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
300 Tamari R, Brown S, Devlin SM, Kosuri S, Maloy MA, Ponce DM, Sauter C, Shaffer B, Dahi P, Young JW, Jakubowski A, Papadopoulos EB, Castro-Malaspina H, Perales MA, Giralt SA, Gyurkocza B. Fractionated Infusion of Hematopoietic Progenitor Cells Does Not Improve Neutrophil Recovery or Survival in Allograft Recipients. Transplant Cell Ther 2021:S2666-6367(21)01025-3. [PMID: 34214736 DOI: 10.1016/j.jtct.2021.06.022] [Reference Citation Analysis]
301 Kumar R, Kimura F, Ahn KW, Hu ZH, Kuwatsuka Y, Klein JP, Pasquini M, Miyamura K, Kato K, Yoshimi A, Inamoto Y, Ichinohe T, Wood WA Jr, Wirk B, Seftel M, Rowlings P, Marks DI, Schultz KR, Gupta V, Dedeken L, George B, Cahn JY, Szer J, Lee JW, Ho AY, Fasth A, Hahn T, Khera N, Dalal J, Bonfim C, Aljurf M, Atsuta Y, Saber W. Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions. Biol Blood Marrow Transplant 2016;22:932-40. [PMID: 26797402 DOI: 10.1016/j.bbmt.2016.01.012] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
302 Hong KW, Choi SM, Lee DG, Cho SY, Lee HJ, Choi JK, Kim SH, Park SH, Choi JH, Yoo JH, Lee JW. Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea. Yonsei Med J 2017;58:362-9. [PMID: 28120567 DOI: 10.3349/ymj.2017.58.2.362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
303 Pandey T, Maximin S, Bhargava P. Imaging of complications from hematopoietic stem cell transplant. Indian J Radiol Imaging 2014;24:327-38. [PMID: 25489126 DOI: 10.4103/0971-3026.143895] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
304 Nishiwaki S, Izumi J. Complete nationwide survey on umbilical cord blood freezing bag breakage in Japan. Cytotherapy 2014;16:1590-4. [PMID: 25287604 DOI: 10.1016/j.jcyt.2014.06.006] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
305 Sinha S, Singh RB, Dohlman TH, Wang M, Taketani Y, Yin J, Dana R. Prevalence of Persistent Corneal Epithelial Defects in Chronic Ocular Graft-Versus-Host Disease. Am J Ophthalmol 2020;218:296-303. [PMID: 32717268 DOI: 10.1016/j.ajo.2020.05.035] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
306 Main H, Munsie M, O'Connor MD. Managing the potential and pitfalls during clinical translation of emerging stem cell therapies. Clin Transl Med 2014;3:10. [PMID: 24949190 DOI: 10.1186/2001-1326-3-10] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
307 Karimov K, Tekgündüz E, Saidov A, Kayıkçı Ö, Boboev K, Koçubaba Ş, Kayumov A, Kılınç A, Adıbelli G, Isroilov A, Türközü TN, Sur HY, Zengin N, Altuntaş F. First hematopoietic cell transplantation in Uzbekistan: Progress through education and cooperation. Transfus Apher Sci 2016;54:60-2. [PMID: 26809683 DOI: 10.1016/j.transci.2016.01.014] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
308 Agarwal RK, Sedai A, Dhimal S, Ankita K, Clemente L, Siddique S, Yaqub N, Khalid S, Itrat F, Khan A, Gilani SK, Marwah P, Soni R, Missiry ME, Hussain MH, Uderzo C, Faulkner L. A prospective international cooperative information technology platform built using open-source tools for improving the access to and safety of bone marrow transplantation in low- and middle-income countries. J Am Med Inform Assoc 2014;21:1125-8. [PMID: 24714444 DOI: 10.1136/amiajnl-2013-002594] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
309 Domingo-Gonzalez R, Martínez-Colón GJ, Smith AJ, Smith CK, Ballinger MN, Xia M, Murray S, Kaplan MJ, Yanik GA, Moore BB. Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2. Am J Respir Crit Care Med 2016;193:186-97. [PMID: 26417909 DOI: 10.1164/rccm.201501-0161OC] [Cited by in Crossref: 40] [Cited by in F6Publishing: 26] [Article Influence: 6.7] [Reference Citation Analysis]
310 Hershenfeld SA, Matelski J, Ling V, Paterson M, Cheung M, Cram P. Utilisation and outcomes of allogeneic hematopoietic cell transplantation in Ontario, Canada, and New York State, USA: a population-based retrospective cohort study. BMJ Open 2020;10:e039293. [PMID: 33130568 DOI: 10.1136/bmjopen-2020-039293] [Reference Citation Analysis]
311 Rovó A, Daikeler T, Halter J, Heim D, Tsakiris DA, Stern M, Waltimo T, Studt JD, Tyndall A, Gratwohl A, Tichelli A. Late altered organ function in very long-term survivors after allogeneic hematopoietic stem cell transplantation: a paired comparison with their HLA-identical sibling donor. Haematologica 2011;96:150-5. [PMID: 20851864 DOI: 10.3324/haematol.2010.030874] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
312 Liu Y, Yuan W, Li M, Cheng L, Yang J, Yin B, Huang X. In situ buccal carcinoma in a teenager after hematopoietic stem cell transplantation: A case report. Medicine (Baltimore) 2020;99:e22781. [PMID: 33120791 DOI: 10.1097/MD.0000000000022781] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
313 Gomez-Arteaga A, Gyurkocza B. Recent advances in allogeneic hematopoietic cell transplantation for acute myeloid leukemia. Curr Opin Hematol 2020;27:115-21. [PMID: 31913152 DOI: 10.1097/MOH.0000000000000572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
314 Parody R, Sánchez-Ortega I, Mussetti A, Patiño B, Arnan M, Pomares H, González-Barca E, Mercadal S, Boqué C, Maluquer C, Carro I, Peña M, Clapés V, Verdesoto S, Bustamante G, Oliveira AC, Baca C, Cabezudo E, Talarn C, Escoda L, Ortega S, García N, Isabel González-Medina M, Sánchez-Salmerón M, Fusté C, Villa J, Carreras E, Domingo-Domènech E, Sureda A. A real-life overview of a hematopoietic cell transplant program throughout a four-year period, including prospective registry, exclusion causes and final donor selection. Bone Marrow Transplant 2021. [PMID: 34711917 DOI: 10.1038/s41409-021-01506-4] [Reference Citation Analysis]
315 Niederwieser D. The Chinese HCT survey: a non-manipulated haploidentical transplantation procedure makes a novel contribution to data sharing within the regional and global transplant registries and to worldwide knowledge. Bone Marrow Transplant 2021;56:1229-31. [PMID: 33514925 DOI: 10.1038/s41409-021-01220-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
316 Peters M, Taylor B, Turner E. An Evidence-Based Review of Total Body Irradiation. J Med Imaging Radiat Sci 2015;46:442-9. [PMID: 31052126 DOI: 10.1016/j.jmir.2015.09.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
317 Jaime-pérez JC, Salazar-cavazos L, Aguilar-calderón P, Herrera-garza JL, Gutiérrez-aguirre CH, Gómez-almaguer D. Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country. Bone Marrow Transplant 2019;54:828-38. [DOI: 10.1038/s41409-018-0338-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
318 Vertès AA. The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter I: current practice and remaining unmet medical needs. Regenerative Medicine 2015;10:331-43. [DOI: 10.2217/rme.15.12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
319 Bubela T, Li MD, Hafez M, Bieber M, Atkins H. Is belief larger than fact: expectations, optimism and reality for translational stem cell research. BMC Med 2012;10:133. [PMID: 23131007 DOI: 10.1186/1741-7015-10-133] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
320 Devine SM. Reprint of: Re-examining the role of high-dose chemotherapy in the treatment of light chain amyloidosis. Biol Blood Marrow Transplant 2014;20:S2-7. [PMID: 24429043 DOI: 10.1016/j.bbmt.2013.11.035] [Reference Citation Analysis]
321 Baldomero H, Aljurf M, Zaidi SZA, Hashmi SK, Ghavamzadeh A, Elhaddad A, Hamladji RM, Ahmed P, Torjemane L, Abboud M, Tbakhi A, Khabori MA, El Quessar A, Bazuaye N, Bekadja MA, Adil S, Fahmy O, Ramzi M, Ibrahim A, Alseraihy A, Ben Abdejalil N, Sarhan M, Huneini MA, Mahmal L, ElSolh H, Hussain F, Nassar A, Al-Hashmi H, Hamidieh AA, Pasquini M, Kodera Y, Kröger N, Mohty M, Jaimovich G, Rolon JM, Paulson K, Greinix H, Weisdorf D, Horowitz M, Nunez J, Gratwohl A, Passweg J, Koh M, Szer J, Niederwieser D, Novitzky N; East-Mediterranean (EMBMT) and African (AfBMT) Blood and Marrow Transplantation Groups and the Worldwide Network for Blood and Marrow Transplantation (WBMT). Narrowing the gap for hematopoietic stem cell transplantation in the East-Mediterranean/African region: comparison with global HSCT indications and trends. Bone Marrow Transplant 2019;54:402-17. [PMID: 30082852 DOI: 10.1038/s41409-018-0275-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
322 Gratwohl A, Brand R, McGrath E, van Biezen A, Sureda A, Ljungman P, Baldomero H, Chabannon C, Apperley J; Joint Accreditation Committee (JACIE) of the International Society for Cellular Therapy and the European Group for Blood and Marrow Transplantation, and the European Leukemia Net. Use of the quality management system "JACIE" and outcome after hematopoietic stem cell transplantation. Haematologica 2014;99:908-15. [PMID: 24488562 DOI: 10.3324/haematol.2013.096461] [Cited by in Crossref: 60] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
323 Cabral-Marques O, Klaver S, Schimke LF, Ascendino ÉH, Khan TA, Pereira PV, Falcai A, Vargas-Hernández A, Santos-Argumedo L, Bezrodnik L, Moreira I, Seminario G, Di Giovanni D, Raccio AG, Porras O, Weber CW, Ferreira JF, Tavares FS, de Carvalho E, Valente CF, Kuntze G, Galicchio M, King A, Rosário-Filho NA, Grota MB, dos Santos Vilela MM, Di Gesu RS, Lima S, de Souza Moura L, Talesnik E, Mansour E, Roxo-Junior P, Aldave JC, Goudouris E, Pinto-Mariz F, Berrón-Ruiz L, Staines-Boone T, Calderón WO, del Carmen Zarate-Hernández M, Grumach AS, Sorensen R, Durandy A, Torgerson TR, Carvalho BT, Espinosa-Rosales F, Ochs HD, Condino-Neto A. First report of the Hyper-IgM syndrome Registry of the Latin American Society for Immunodeficiencies: novel mutations, unique infections, and outcomes. J Clin Immunol 2014;34:146-56. [PMID: 24402618 DOI: 10.1007/s10875-013-9980-4] [Cited by in Crossref: 56] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
324 Ali N, Adil SN, Shaikh MU. Autologous Hematopoietic Stem Cell Transplantation-10 Years of Data From a Developing Country. Stem Cells Transl Med. 2015;4:873-877. [PMID: 26032748 DOI: 10.5966/sctm.2015-0015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
325 Boquett JA, Zagonel-Oliveira M, Jobim LF, Jobim M, Gonzaga L Jr, Veronez MR, Fagundes NJR, Schüler-Faccini L. Spatial analyzes of HLA data in Rio Grande do Sul, south Brazil: genetic structure and possible correlation with autoimmune diseases. Int J Health Geogr 2018;17:34. [PMID: 30217207 DOI: 10.1186/s12942-018-0154-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
326 Estcourt LJ, Gregg R, Stanworth S, Doree C, Trivella M, Murphy MF, Tinmouth A. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2014:CD010982. [PMID: 25722650 DOI: 10.1002/14651858.CD010982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
327 Nishiwaki S. Roles of volunteers and professionals in medical development -- insights from the development of Allo-HSCT. Jpn J Clin Oncol 2015;45:502-3. [PMID: 25813660 DOI: 10.1093/jjco/hyv040] [Reference Citation Analysis]
328 Caliskan K, Can G. Determining the symptoms and coping methods of patients at home after hematopoietic stem cell transplantation. Support Care Cancer 2022. [PMID: 35376995 DOI: 10.1007/s00520-022-07017-2] [Reference Citation Analysis]
329 Bazarbachi A, Labopin M, Ghavamzadeh A, Giebel S, Al-zahrani H, Ladeb S, Leone G, Abdel-rahman F, Liso V, Hamidieh AA, Rasheed W, Ibrahim A, Alabdulaaly A, Kyrcz-krzemien S, Arnold R, Kharfan-dabaja MA, Alimoghaddam K, Aljurf M, Mohty M. Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers. Bone Marrow Transplant 2013;48:1065-9. [DOI: 10.1038/bmt.2013.1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
330 Al Mamari S, Al Saadi A, Al Zaabi R, Al Jamalani A, Al Qassabi J, Pathare A, Al-Khabori M. Measurement of hematopoietic progenitor cells using XN2000 hematology analyzer. Int J Lab Hematol 2021. [PMID: 34409726 DOI: 10.1111/ijlh.13683] [Reference Citation Analysis]
331 Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A, Frauendorfer K; European Group for Blood and Marrow Transplantation EBMT. The EBMT activity survey 2009: trends over the past 5 years. Bone Marrow Transplant 2011;46:485-501. [PMID: 21358689 DOI: 10.1038/bmt.2011.11] [Cited by in Crossref: 112] [Cited by in F6Publishing: 102] [Article Influence: 10.2] [Reference Citation Analysis]
332 Saboo US, Amparo F, Abud TB, Schaumberg DA, Dana R. Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease. Ophthalmology 2015;122:1669-74. [PMID: 26001816 DOI: 10.1016/j.ophtha.2015.04.011] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
333 Yeh AC, Khan MA, Harlow J, Biswas AR, Akter M, Ferdous J, Ara T, Islam M, Caron M, Barron AM, Moran J, Brezina M, Nazneen H, Kamruzzaman M, Saha A, Marshall A, Afrose S, Stowell C, Preffer F, Bangsberg D, Goodman A, Attar E, McAfee S, Spitzer TR, Dey BR. Hematopoietic Stem-Cell Transplantation in the Resource-Limited Setting: Establishing the First Bone Marrow Transplantation Unit in Bangladesh. J Glob Oncol 2018;4:1-10. [PMID: 30241180 DOI: 10.1200/JGO.2016.006460] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
334 Vijapura A, Levine HB, Donato M, Hartzband MA, Baker M, Klein GR. Total Hip Arthroplasty in Patients With Avascular Necrosis After Hematopoietic Stem Cell Transplantation. Orthopedics 2018;41:e257-61. [PMID: 29451944 DOI: 10.3928/01477447-20180213-02] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
335 Cook MM. Mesenchymal Stem Cells and Haematopoietic Stem Cell Culture. In: Chase LG, Vemuri MC, editors. Mesenchymal Stem Cell Therapy. Totowa: Humana Press; 2013. pp. 161-72. [DOI: 10.1007/978-1-62703-200-1_9] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
336 Holbro A, Ahmad I, Cohen S, Roy J, Lachance S, Chagnon M, Leblanc R, Bernard L, Busque L, Roy DC, Sauvageau G, Kiss TL. Safety and Cost-Effectiveness of Outpatient Autologous Stem Cell Transplantation in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation 2013;19:547-51. [DOI: 10.1016/j.bbmt.2012.12.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
337 Ries F, Alflen A, Aranda Lopez P, Beckert H, Theobald M, Schild H, Teschner D, Radsak MP. Antifungal Drugs Influence Neutrophil Effector Functions. Antimicrob Agents Chemother 2019;63:e02409-18. [PMID: 30910895 DOI: 10.1128/AAC.02409-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
338 Talamo G, Rakszawski KL, Rybka WB, Dolloff NG, Malysz J, Berno T, Zangari M. Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high-dose melphalan in patients with multiple myeloma. Eur J Haematol 2012;89:145-50. [DOI: 10.1111/j.1600-0609.2012.01795.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
339 Radich JP. Allogeneic transplant for chronic myeloid leukemia in 2010. Ther Adv Hematol 2010;1:5-13. [PMID: 23556067 DOI: 10.1177/2040620710388339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
340 Halter JP, van Walraven SM, Worel N, Bengtsson M, Hägglund H, Nicoloso de Faveri G, Shaw BE, Schmidt AH, Fechter M, Madrigal A. Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT). Bone Marrow Transplant. 2013;48:220-225. [PMID: 22773129 DOI: 10.1038/bmt.2012.119] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
341 Lucena CM, Rovira M, Gabarrús A, Filella X, Martínez C, Domingo R, Torres A, Agustí C. The clinical value of biomarkers in respiratory complications in hematopoietic SCT. Bone Marrow Transplant 2017;52:415-22. [PMID: 27797370 DOI: 10.1038/bmt.2016.280] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
342 Jung DW, Williams DR. Reawakening atlas: chemical approaches to repair or replace dysfunctional musculature. ACS Chem Biol 2012;7:1773-90. [PMID: 23043623 DOI: 10.1021/cb3003368] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
343 Gordon WJ, Baronas J, Lane WJ. A FHIR Human Leukocyte Antigen (HLA) Interface for Platelet Transfusion Support. Appl Clin Inform 2017;8:603-11. [PMID: 28850154 DOI: 10.4338/ACI-2017-01-CR-0010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
344 Snowden JA, McGrath E, Orchard K, Kröger N, Sureda A, Gratwohl A. Visions for a JACIE Quality Management System 4.0. Bone Marrow Transplant 2021. [PMID: 34588628 DOI: 10.1038/s41409-021-01467-8] [Reference Citation Analysis]
345 Wood WA, Brazauskas R, Hu ZH, Abdel-Azim H, Ahmed IA, Aljurf M, Badawy S, Beitinjaneh A, George B, Buchbinder D, Cerny J, Dedeken L, Diaz MA, Freytes CO, Ganguly S, Gergis U, Almaguer DG, Gupta A, Hale G, Hashmi SK, Inamoto Y, Kamble RT, Adekola K, Kindwall-Keller T, Knight J, Kumar L, Kuwatsuka Y, Law J, Lazarus HM, LeMaistre C, Olsson RF, Pulsipher MA, Savani BN, Schultz KR, Saad AA, Seftel M, Seo S, Shea TC, Steinberg A, Sullivan K, Szwajcer D, Wirk B, Yared J, Yong A, Dalal J, Hahn T, Khera N, Bonfim C, Atsuta Y, Saber W. Country-Level Macroeconomic Indicators Predict Early Post-Allogeneic Hematopoietic Cell Transplantation Survival in Acute Lymphoblastic Leukemia: A CIBMTR Analysis. Biol Blood Marrow Transplant 2018;24:1928-35. [PMID: 29567340 DOI: 10.1016/j.bbmt.2018.03.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
346 Passweg JR, Baldomero H, Bader P, Bonini C, Cesaro S, Dreger P, Duarte RF, Dufour C, Falkenburg JH, Farge-Bancel D, Gennery A, Kröger N, Lanza F, Nagler A, Sureda A, Mohty M; European Society for Blood and Marrow Transplantation (EBMT). Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants. Bone Marrow Transplant 2015;50:476-82. [PMID: 25642761 DOI: 10.1038/bmt.2014.312] [Cited by in Crossref: 135] [Cited by in F6Publishing: 134] [Article Influence: 19.3] [Reference Citation Analysis]
347 Ge M, Zhang Y, Hao Q, Zhao Y, Dong B. Effects of mesenchymal stem cells transplantation on cognitive deficits in animal models of Alzheimer's disease: A systematic review and meta-analysis. Brain Behav 2018;8:e00982. [PMID: 29877067 DOI: 10.1002/brb3.982] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
348 Brown N, Williams R. Cord blood banking - bio-objects on the borderlands between community and immunity. Life Sci Soc Policy 2015;11:11. [PMID: 26449725 DOI: 10.1186/s40504-015-0029-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.1] [Reference Citation Analysis]
349 Liso A, Neri M, Maglietta F, La Russa R, Turillazzi E. Hematopoietic Stem Cell Transplantation: A Bioethical Lens. Stem Cells Int 2017;2017:1286246. [PMID: 28740510 DOI: 10.1155/2017/1286246] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
350 Salas MQ, Atenafu EG, Law AD, Lam W, Pasic I, Chen C, Kim DDH, Michelis FV, Gerbitz A, Lipton JH, Mattsson J, Kumar R, Viswabandya A. Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections. Leuk Lymphoma 2021;:1-11. [PMID: 34435547 DOI: 10.1080/10428194.2021.1966781] [Reference Citation Analysis]
351 Bogunia-Kubik K, Łacina P. Non-KIR NK cell receptors: Role in transplantation of allogeneic haematopoietic stem cells. Int J Immunogenet 2021;48:157-71. [PMID: 33352617 DOI: 10.1111/iji.12523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
352 Westblade LF, Jennemann R, Branda JA, Bythrow M, Ferraro MJ, Garner OB, Ginocchio CC, Lewinski MA, Manji R, Mochon AB, Procop GW, Richter SS, Rychert JA, Sercia L, Burnham CA. Multicenter study evaluating the Vitek MS system for identification of medically important yeasts. J Clin Microbiol 2013;51:2267-72. [PMID: 23658267 DOI: 10.1128/JCM.00680-13] [Cited by in Crossref: 72] [Cited by in F6Publishing: 31] [Article Influence: 8.0] [Reference Citation Analysis]
353 Tang F, Mo X, Zhang X, Wang Y, Yan C, Chen Y, Chen H, Han W, Chen Y, Wang F, Wang J, Sun Y, Zhang Y, Liu K, Huang X, Xu L. Influence of the degree of donor bone marrow hyperplasia on patient clinical outcomes after allogeneic hematopoietic stem cell transplantation. Sci China Life Sci 2020;63:138-47. [PMID: 31432375 DOI: 10.1007/s11427-018-9509-y] [Reference Citation Analysis]
354 Lee J, Dykstra B, Sackstein R, Rossi DJ. Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells. Curr Opin Hematol 2015;22:317-23. [PMID: 26049752 DOI: 10.1097/MOH.0000000000000147] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
355 Lv J, Wang L, Gao Y, Ding YQ, Liu F. 5-hydroxytryptamine synthesized in the aorta-gonad-mesonephros regulates hematopoietic stem and progenitor cell survival. J Exp Med 2017;214:529-45. [PMID: 28031476 DOI: 10.1084/jem.20150906] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
356 Gratwohl A, Duarte R, Snowden JA, van Biezen A, Baldomero H, Apperley J, Cornelissen J, Greinix HT, Grath EM, Mohty M, Kroeger N, Nagler A, Niederwieser D, Putter H, Brand R; Joint Accreditation Committee JACIE. Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia. EClinicalMedicine 2019;15:33-41. [PMID: 31709412 DOI: 10.1016/j.eclinm.2019.07.019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
357 Green DE, Rubin CT. Consequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursors. Bone 2014;63:87-94. [PMID: 24607941 DOI: 10.1016/j.bone.2014.02.018] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 6.9] [Reference Citation Analysis]
358 Crighton GL, Estcourt LJ, Wood EM, Trivella M, Doree C, Stanworth S. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2015;:CD010981. [PMID: 26422767 DOI: 10.1002/14651858.CD010981.pub2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
359 Hashmi SK, Srivastava A, Rasheed W, Adil S, Wu T, Jagasia M, Nassar A, Hwang WY, Hamidieh AA, Greinix HT, Pasquini MC, Apperley JF, Aljurf M. Cost and quality issues in establishing hematopoietic cell transplant program in developing countries. Hematology/Oncology and Stem Cell Therapy 2017;10:167-72. [DOI: 10.1016/j.hemonc.2017.05.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
360 Nakamura ZM, Nash RP, Quillen LJ, Richardson DR, McCall RC, Park EM. Psychiatric Care in Hematopoietic Stem Cell Transplantation. Psychosomatics. 2019;60:227-237. [PMID: 30733043 DOI: 10.1016/j.psym.2019.01.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
361 Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, Murphy MF. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2015;:CD010984. [PMID: 26505729 DOI: 10.1002/14651858.CD010984.pub2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
362 Yousefi F, Lavi Arab F, Saeidi K, Amiri H, Mahmoudi M. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection. J Neuroimmunol 2019;328:20-34. [PMID: 30557687 DOI: 10.1016/j.jneuroim.2018.11.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
363 Demaret P, Pettersen G, Hubert P, Teira P, Emeriaud G. The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit. Ann Intensive Care 2012;2:14. [PMID: 22691690 DOI: 10.1186/2110-5820-2-14] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
364 Kayal S, Sharma A, Iqbal S, Tejomurtula T, Cyriac SL, Raina V. High-Dose Chemotherapy and Autologous Stem Cell Transplantation in Multiple Myeloma: A Single Institution Experience at All India Institute of Medical Sciences, New Delhi, Using Non-Cryopreserved Peripheral Blood Stem Cells. Clinical Lymphoma Myeloma and Leukemia 2014;14:140-7. [DOI: 10.1016/j.clml.2013.09.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
365 Yafour N, Bekadja MA, Chevallier P, Cabrera Q, Coman T, Elkababri M, Hamzy F, Quessar A, Laamiri A, Pochon C, Yakoub-Agha I, Harif M. [Establishment of Hematopoietic cell transplantation program in developing countries : Guidelines from the francophone Society of bone marrow transplantation and cellular therapy (SFGM-TC)]. Bull Cancer 2021:S0007-4551(21)00204-6. [PMID: 34247762 DOI: 10.1016/j.bulcan.2021.02.015] [Reference Citation Analysis]
366 Hamdeh S, Abdelrahman AAM, Elsallabi O, Pathak R, Giri S, Mosalpuria K, Bhatt VR. Clinical approach to diarrheal disorders in allogeneic hematopoietic stem cell transplant recipients. World J Hematol 2016; 5(1): 23-30 [DOI: 10.5315/wjh.v5.i1.23] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
367 Singla A, Hogan WJ, Ansell SM, Buadi FK, Dingli D, Dispenzieri A, Gastineau DA, Gertz MA, Hayman SR, Inwards DJ, Johnston PB, Lacy MQ, Litzow MR, Micallef IN, Porrata LF, Kumar SK. Incidence of supraventricular arrhythmias during autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2013;19:1233-7. [PMID: 23747600 DOI: 10.1016/j.bbmt.2013.05.019] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
368 Brooks RW, Robbins PD. Treating Age-Related Diseases with Somatic Stem Cells. In: Mettinger KL, Rameshwar P, Kumar V, editors. Exosomes, Stem Cells and MicroRNA. Cham: Springer International Publishing; 2018. pp. 29-45. [DOI: 10.1007/978-3-319-74470-4_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
369 Switzer GE, Bruce JG, Kiefer DM, Kobusingye H, Abebe KZ, Drexler R, Besser RM, Confer DL, Horowitz MM, King RJ, Shaw BE, Riches M, Hayes-Lattin B, Linenberger M, Bolwell B, Rowley SD, Litzow MR, Pulsipher MA. Health-Related Quality-of-Life Comparison of Adult Related and Unrelated HSC Donors: An RDSafe Study. Biol Blood Marrow Transplant 2020;26:2365-71. [PMID: 32829080 DOI: 10.1016/j.bbmt.2020.08.016] [Reference Citation Analysis]
370 Tollemar V, Tudzarovski N, Warfvinge G, Yarom N, Remberger M, Heymann R, Garming Legert K, Sugars RV. Histopathological Grading of Oral Mucosal Chronic Graft-versus-Host Disease: Large Cohort Analysis. Biol Blood Marrow Transplant 2020;26:1971-9. [PMID: 32659433 DOI: 10.1016/j.bbmt.2020.06.031] [Reference Citation Analysis]
371 Arrieta-bolaños E, Oliveira DC, Barquera R. Differential admixture, human leukocyte antigen diversity, and hematopoietic cell transplantation in Latin America: challenges and opportunities. Bone Marrow Transplant 2020;55:496-504. [DOI: 10.1038/s41409-019-0737-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
372 Kumar L, Malik PS, Prakash G, Prabu R, Radhakrishnan V, Katyal S, Hariprasad R. Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India. Ann Hematol 2011;90:1317-28. [PMID: 21409382 DOI: 10.1007/s00277-011-1205-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
373 Suzuki A, Kondoh Y, Fischer A. Recent advances in connective tissue disease related interstitial lung disease. Expert Rev Respir Med 2017;11:591-603. [PMID: 28544856 DOI: 10.1080/17476348.2017.1335600] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
374 Galgano L, Hutt D. HSCT: How Does It Work? In: Kenyon M, Babic A, editors. The European Blood and Marrow Transplantation Textbook for Nurses. Cham: Springer International Publishing; 2018. pp. 23-36. [DOI: 10.1007/978-3-319-50026-3_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
375 Han T, Yang CS, Chang KY, Zhang D, Imam FB, Rana TM. Identification of novel genes and networks governing hematopoietic stem cell development. EMBO Rep 2016;17:1814-28. [PMID: 27797851 DOI: 10.15252/embr.201642395] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
376 Lumi C, Macagnan FE, Kessler A, De Toni P, Raffone AM. Decrease in physical performance during the hospitalisation phase of haematopoietic stem cell transplantation. International Journal of Therapy and Rehabilitation 2019;26:1-12. [DOI: 10.12968/ijtr.2018.0012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
377 Leonard A, Bertaina A, Bonfim C, Cohen S, Prockop S, Purtill D, Russell A, Boelens JJ, Wynn R, Ruggeri A, Abraham A. Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation. Cytotherapy 2021:S1465-3249(21)00784-2. [PMID: 34879990 DOI: 10.1016/j.jcyt.2021.09.003] [Reference Citation Analysis]
378 Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2015;:CD010983. [PMID: 26576687 DOI: 10.1002/14651858.CD010983.pub2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
379 Potter P, Eisenberg S, Cain KC, Berry DL. Orange Interventions for Symptoms Associated With Dimethyl Sulfoxide During Stem Cell Reinfusions: A Feasibility Study. Cancer Nursing 2011;34:361-8. [DOI: 10.1097/ncc.0b013e31820641a5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
380 Cheng AP, Cheng MP, Loy CJ, Lenz JS, Chen K, Smalling S, Burnham P, Timblin KM, Orejas JL, Silverman E, Polak P, Marty FM, Ritz J, De Vlaminck I. Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation. Proc Natl Acad Sci USA 2022;119:e2113476118. [DOI: 10.1073/pnas.2113476118] [Reference Citation Analysis]
381 Devine SM. Re-Examining the Role of High-Dose Chemotherapy in the Treatment of Light Chain Amyloidosis. Biology of Blood and Marrow Transplantation 2014;20:14-9. [DOI: 10.1016/j.bbmt.2013.11.015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
382 Naymagon S, Naymagon L, Wong SY, Ko HM, Renteria A, Levine J, Colombel JF, Ferrara J. Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol. 2017;14:711-726. [PMID: 28951581 DOI: 10.1038/nrgastro.2017.126] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 7.8] [Reference Citation Analysis]
383 Leon Rodriguez E, Rivera Franco MM. Outcomes of Hematopoietic Stem Cell Transplantation at a Limited-Resource Center in Mexico Are Comparable to Those in Developed Countries. Biol Blood Marrow Transplant 2017;23:1998-2003. [PMID: 28733265 DOI: 10.1016/j.bbmt.2017.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
384 Faulkner L, Uderzo C, Khalid S, Marwah P, Soni R, Yaqub N, Amanat S, Fatima I, Gilani SK, Zahra T, Ramprakash S, Gooneratne L, Dissanayake R, Williams S, Rathnayake W, Srinivas R, Sedai A, Kumari A, Parmar L, Dhanya R, Agarwal RK. ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia. Blood Adv 2017;1:792-801. [PMID: 29296723 DOI: 10.1182/bloodadvances.2016004119] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
385 Rivera-franco MM, Leon-rodriguez E, Castro-saldaña HL. Costs of hematopoietic stem cell transplantation in a developing country. Int J Hematol 2017;106:573-80. [DOI: 10.1007/s12185-017-2278-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
386 Carapito R, Aouadi I, Pichot A, Spinnhirny P, Morlon A, Kotova I, Macquin C, Rolli V, Cesbron A, Gagne K, Oudshoorn M, van der Holt B, Labalette M, Spierings E, Picard C, Loiseau P, Tamouza R, Toubert A, Parissiadis A, Dubois V, Paillard C, Maumy-Bertrand M, Bertrand F, von dem Borne PA, Kuball JHE, Michallet M, Lioure B, Peffault de Latour R, Blaise D, Cornelissen JJ, Yakoub-Agha I, Claas F, Moreau P, Charron D, Mohty M, Morishima Y, Socié G, Bahram S. Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status. Bone Marrow Transplant 2020;55:1367-78. [PMID: 32286503 DOI: 10.1038/s41409-020-0886-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]